Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________
  FORM 10-Q
_______________________________________________________________________
x
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2013
or
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _______ to _______
Commission File Number 1-2376
__________________________________________________________________________
FMC CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________  
Delaware
 
94-0479804
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
1735 Market Street
Philadelphia, Pennsylvania
 
19103
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: 215-299-6000
__________________________________________________________________________
INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS    YES   x     NO   o
INDICATE BY CHECK MARK WHETHER THE REGISTRANT HAS SUBMITTED ELECTRONICALLY AND POSTED ON ITS CORPORATE WEBSITE, IF ANY, EVERY INTERACTIVE DATA FILE REQUIRED TO BE SUBMITTED AND POSTED PURSUANT TO RULE 405 OF REGULATION S-T DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO SUBMIT AND POST SUCH FILES)    YES   x     NO   o
INDICATE BY CHECK MARK WHETHER THE REGISTRANT IS A LARGE ACCELERATED FILER, AN ACCELERATED FILER, A NON-ACCELERATED FILER OR A SMALLER REPORTING COMPANY. SEE THE DEFINITIONS OF “LARGE ACCELERATED FILER,” “ACCELERATED FILER,” AND “SMALLER REPORTING COMPANY” IN RULE 12B-2 OF THE EXCHANGE ACT. (CHECK ONE):
LARGE ACCELERATED FILER
 
x
  
ACCELERATED FILER
 
o
 
 
 
 
 
 
 
NON-ACCELERATED FILER
 
o
  
SMALLER REPORTING COMPANY
 
o
INDICATE BY CHECK MARK WHETHER THE REGISTRANT IS A SHELL COMPANY (AS DEFINED IN RULE 12B-2 OF THE EXCHANGE ACT)    YES   o     NO   x
INDICATE THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE ISSUER’S CLASSES OF COMMON STOCK, AS OF THE LATEST PRACTICABLE DATE
Class
 
Outstanding at September 30, 2013
Common Stock, par value $0.10 per share
 
133,273,849

Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
INDEX
 
 
Page
No.


2
Table of Contents

PART I - FINANCIAL INFORMATION
 
ITEM 1.    FINANCIAL STATEMENTS

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 
(in Millions, Except Per Share Data)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
 
(unaudited)
 
(unaudited)
Revenue
$
957.4

 
$
821.9

 
$
2,744.1

 
$
2,494.4

Costs and Expenses
 
 
 
 
 
 
 
Costs of sales and services
653.0

 
523.9

 
1,758.6

 
1,547.6

 
 
 
 
 
 
 
 
Gross margin
304.4

 
298.0

 
985.5

 
946.8

 
 
 
 
 
 
 
 
Selling, general and administrative expenses
124.9

 
118.7

 
374.1

 
357.3

Research and development expenses
29.0

 
28.1

 
84.7

 
82.4

Restructuring and other charges (income)
32.1

 
5.5

 
47.3

 
9.1

Total costs and expenses
839.0

 
676.2

 
2,264.7

 
1,996.4

Income from continuing operations before equity in (earnings) loss of affiliates, interest expense, net and income taxes
118.4

 
145.7

 
479.4

 
498.0

Equity in (earnings) loss of affiliates
0.1

 
0.2

 
0.5

 
0.3

Interest expense, net
9.8

 
9.8

 
31.4

 
30.3

Income from continuing operations before income taxes
108.5

 
135.7

 
447.5

 
467.4

Provision for income taxes
32.0

 
29.9

 
113.1

 
113.2

Income from continuing operations
76.5

 
105.8

 
334.4

 
354.2

Discontinued operations, net of income taxes
(56.6
)
 
(11.2
)
 
(58.3
)
 
(24.7
)
Net income
19.9

 
94.6

 
276.1

 
329.5

Less: Net income attributable to noncontrolling interests
2.0

 
4.6

 
9.3

 
15.5

Net income attributable to FMC stockholders
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

Amounts attributable to FMC stockholders:
 
 
 
 
 
 
 
Continuing operations, net of income taxes
$
74.5

 
$
101.2

 
$
325.1

 
$
338.7

Discontinued operations, net of income taxes
(56.6
)
 
(11.2
)
 
(58.3
)
 
(24.7
)
Net income attributable to FMC stockholders
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

Basic earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
Continuing operations
$
0.55

 
$
0.73

 
$
2.39

 
$
2.45

Discontinued operations
(0.42
)
 
(0.08
)
 
(0.43
)
 
(0.18
)
Net income attributable to FMC stockholders
$
0.13

 
$
0.65

 
$
1.96

 
$
2.27

Diluted earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
Continuing operations
$
0.55

 
$
0.73

 
$
2.38

 
$
2.44

Discontinued operations
(0.42
)
 
(0.08
)
 
(0.43
)
 
(0.18
)
Net income attributable to FMC stockholders
$
0.13

 
$
0.65

 
$
1.95

 
$
2.26

The accompanying notes are an integral part of these condensed consolidated financial statements.


3
Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
 
(unaudited)
 
(unaudited)
Net Income
$
19.9

 
$
94.6

 
$
276.1

 
$
329.5

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
Foreign currency translation adjustments (1)
14.9

 
13.3

 
1.4

 
(4.9
)
 
 
 
 
 
 
 
 
Derivative instruments:
 
 
 
 
 
 
 
Unrealized hedging gains (losses) and other, net of tax of $(0.5) and $(2.0) for the three and nine months ended 2013 and $0.6 and zero for the three and nine months ended 2012, respectively
(0.9
)
 
1.1

 
(4.1
)
 
0.4

Reclassification of deferred hedging (gains) losses and other, included in net income, net of tax of $0.4 and $(0.6) for the three and nine months ended 2013 and $1.4 and $2.5 for the three and nine months ended 2012, respectively (3)
1.2

 
2.6

 
(0.9
)
 
4.2

Total derivative instruments, net of tax of $(0.1) and $(2.6) for the three and nine months ended 2013 and $2.0 and $2.5 for the three and nine months ended 2012, respectively
0.3

 
3.7

 
(5.0
)
 
4.6

 
 
 
 
 
 
 
 
Pension and other postretirement benefits:
 
 
 
 
 
 
 
Unrealized actuarial gains (losses) and prior service (costs) credits, net of tax of $(0.1) and zero for the three and nine months ended 2013 and $0.8 and $0.8 for the three and nine months ended 2012, respectively (2)
(0.3
)
 
(1.6
)
 
(0.2
)
 
(1.2
)
Reclassification of net actuarial and other (gain) loss and amortization of prior service costs, included in net income, net of tax of $4.1 and $17.1 for the three and nine months ended 2013 and $4.8 and $14.5 for the three and nine months ended 2012, respectively (3)
6.2

 
6.4

 
27.7

 
22.2

Total pension and other postretirement benefits, net of tax of $4.0 and $17.1 for the three and nine months ended 2013 and $5.6 and $15.3 for the three and nine months ended 2012, respectively
5.9

 
4.8

 
27.5

 
21.0

 
 
 
 
 
 
 
 
Other comprehensive income (loss), net of tax
21.1

 
21.8

 
23.9

 
20.7

Comprehensive income
$
41.0

 
$
116.4

 
$
300.0

 
$
350.2

Less: Comprehensive income attributable to the noncontrolling interest
1.8

 
4.8

 
9.7

 
15.4

Comprehensive income attributable to FMC stockholders
$
39.2

 
$
111.6

 
$
290.3

 
$
334.8

____________________ 
(1)
Income taxes are not provided on the equity in undistributed earnings of our foreign subsidiaries or affiliates since it is our intention that such earnings will remain invested in those affiliates permanently, however see Note 16, regarding the impact from the expected sale of our discontinued FMC Peroxygens segment on certain of these foreign subsidiaries.
(2)
At December 31st of each year, we remeasure our pension and postretirement plan obligations at which time we record any actuarial gains (losses) and prior service (costs) credits to other comprehensive income. The interim adjustments noted above reflect the foreign currency translation impacts from the unrealized actuarial gains (losses) and prior service (costs) credits related to our foreign pension and postretirement plans.
(3)
For more detail on the components of these reclassifications and the affected line item in the Condensed Consolidated Statements of Income see Note 14.


4
Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 
(in Millions, Except Share and Par Value Data)
September 30, 2013
 
December 31, 2012
ASSETS
(unaudited)
Current assets
 
 
 
Cash and cash equivalents
$
109.6

 
$
77.1

Trade receivables , net of allowance of $27.8 at 2013 and $26.8 at 2012
1,179.6

 
1,073.7

Inventories
707.7

 
642.4

Prepaid and other current assets
205.4

 
172.9

Deferred income taxes
124.3

 
123.4

Current assets of discontinued operations held for sale
284.1

 
92.4

Total current assets
2,610.7

 
2,181.9

Investments
29.5

 
26.1

Property, plant and equipment, net
1,163.5

 
956.2

Goodwill
396.0

 
277.6

Other intangibles, net
272.3

 
205.7

Other assets
250.0

 
247.6

Deferred income taxes
208.8

 
234.6

Noncurrent assets of discontinued operations held for sale
—

 
244.2

Total assets
$
4,930.8

 
$
4,373.9

LIABILITIES AND EQUITY
 
 
 
Current liabilities
 
 
 
Short-term debt and current portion of long-term debt
$
942.4

 
$
55.6

Accounts payable, trade and other
388.9

 
404.2

Advance payments from customers
18.1

 
140.2

Accrued and other liabilities
257.8

 
254.1

Accrued customer rebates
334.9

 
141.7

Guarantees of vendor financing
21.3

 
31.4

Accrued pension and other postretirement benefits, current
21.3

 
21.3

Income taxes
35.4

 
32.9

Current liabilities of discontinued operations held for sale
46.4

 
54.1

Total current liabilities
2,066.5

 
1,135.5

Long-term debt, less current portion
771.8

 
908.8

Accrued pension and other postretirement benefits, long-term
315.8

 
375.8

Environmental liabilities, continuing and discontinued
164.3

 
200.2

Deferred income taxes
45.4

 
—

Noncurrent liabilities of discontinued operations held for sale
—

 
3.3

Other long-term liabilities
193.4

 
195.5

Commitments and contingent liabilities (Note 18)

 

Equity
 
 
 
Preferred stock , no par value, authorized 5,000,000 shares; no shares issued in 2013 or 2012
—

 
—

Common stock , $0.10 par value, authorized 260,000,000 shares; 185,983,792 issued shares at 2013 and 2012
18.6

 
18.6

Capital in excess of par value of common stock
395.6

 
481.9

Retained earnings
2,748.2

 
2,536.5

Accumulated other comprehensive income (loss)
(385.4
)
 
(408.9
)
Treasury stock , common, at cost: 52,709,943 shares at 2013 and 48,313,414 shares at 2012
(1,452.9
)
 
(1,147.8
)
Total FMC stockholders’ equity
1,324.1

 
1,480.3

Noncontrolling interests
49.5

 
74.5

Total equity
1,373.6

 
1,554.8

Total liabilities and equity
4,930.8

 
4,373.9

The accompanying notes are an integral part of these condensed consolidated financial statements.

5
Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(in Millions)
Nine Months Ended September 30
2013
 
2012
 
(unaudited)
Cash provided (required) by operating activities of continuing operations:
 
 
 
Net income
$
276.1

 
$
329.5

Discontinued operations
58.3

 
24.7

Income from continuing operations
$
334.4

 
$
354.2

Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations:
 
 
 
Depreciation and amortization
91.7

 
84.6

Equity in (earnings) loss of affiliates
0.5

 
0.3

Restructuring and other charges (income)
47.3

 
9.1

Deferred income taxes
27.8

 
32.3

Pension and other postretirement benefits
48.2

 
43.0

Share-based compensation
12.2

 
12.7

Excess tax benefits from share-based compensation
(6.7
)
 
(7.4
)
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
 
 
 
Trade receivables, net
(93.9
)
 
(82.6
)
Guarantees of vendor financing
(10.1
)
 
9.0

Inventories
(14.0
)
 
(143.9
)
Other current assets and other assets
2.2

 
(35.8
)
Accounts payable
0.6

 
3.7

Accrued and other current liabilities and other liabilities
(18.9
)
 
13.1

Advance payments from customers
(122.1
)
 
(66.6
)
Accrued payroll
(8.1
)
 
(7.7
)
Accrued customer rebates
194.8

 
163.3

Income taxes
(29.1
)
 
65.2

Pension and other postretirement benefit contributions
(63.1
)
 
(72.7
)
Environmental spending, continuing, net of recoveries
(4.3
)
 
(4.3
)
Restructuring and other spending
(8.8
)
 
(0.6
)
Cash provided (required) by operating activities
380.6

 
368.9

Cash provided (required) by operating activities of discontinued operations:
 
 
 
Environmental spending, net of recoveries
(19.2
)
 
(12.2
)
Operating activities of discontinued operations held for sale
(5.2
)
 
2.2

Payments of other discontinued reserves, net of recoveries
(7.0
)
 
(26.3
)
Cash provided (required) by operating activities of discontinued operations
(31.4
)
 
(36.3
)
The accompanying notes are an integral part of these condensed consolidated financial statements.
(continued)

6
Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
 
(in Millions)
Nine Months Ended September 30
2013
 
2012
 
(unaudited)
Cash provided (required) by investing activities:
 
 
 
Capital expenditures
$
(159.6
)
 
$
(108.7
)
Proceeds from disposal of property, plant and equipment
2.1

 
0.5

Acquisitions, net of cash acquired
(339.6
)
 
(114.2
)
Investments in nonconsolidated affiliates
(6.2
)
 
(9.7
)
Other investing activities
(52.0
)
 
(19.2
)
Cash provided (required) by investing activities of continuing operations
(555.3
)
 
(251.3
)
Cash provided (required) by investing activities of discontinued operations held for sale
(15.2
)
 
(19.0
)
Cash provided (required) by financing activities:
 
 
 
Net borrowings (repayments) under committed credit facilities
(130.0
)
 
24.0

Increase (decrease) in short-term debt
869.5

 
32.3

Repayments of long-term debt
(0.5
)
 
(17.3
)
Proceeds from borrowings of long-term debt
11.6

 
5.4

Financing fees
(0.9
)
 
—

Distributions to noncontrolling interests
(9.9
)
 
(15.4
)
Acquisition of noncontrolling interests
(80.0
)
 
—

Issuances of common stock, net
9.9

 
12.6

Excess tax benefits from share-based compensation
6.7

 
7.4

Dividends paid
(55.6
)
 
(35.4
)
Repurchases of common stock under publicly announced program
(359.9
)
 
(144.9
)
Other repurchases of common stock
(6.7
)
 
(3.8
)
Contingent consideration paid
(0.5
)
 
(2.0
)
Cash provided (required) by financing activities
253.7

 
(137.1
)
Effect of exchange rate changes on cash and cash equivalents
0.1

 
0.3

Increase (decrease) in cash and cash equivalents
32.5

 
(74.5
)
Cash and cash equivalents, beginning of period
77.1

 
158.9

Cash and cash equivalents, end of period
$
109.6

 
$
84.4

Supplemental disclosure of cash flow information: Cash paid for interest, net of capitalized interest was $29.5 million and $24.9 million , and income taxes paid, net of refunds were $124.6 million and $30.0 million for the nine months ended September 30, 2013 and 2012 , respectively. Non-cash additions to property, plant and equipment were $5.5 million and $2.2 million for September 30, 2013 and 2012.
See Note 13 regarding quarterly cash dividend and acquisition of noncontrolling interest.

The accompanying notes are an integral part of these condensed consolidated financial statements.

7
Table of Contents

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1: Financial Information and Accounting Policies
In our opinion the condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations and cash flows for the nine months ended September 30, 2013 and 2012 , and our financial position as of September 30, 2013 . All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the nine months ended September 30, 2013 and 2012 are not necessarily indicative of the results of operations for the full year. The condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012 , and the related condensed consolidated statements of income, condensed consolidated statements of comprehensive income and condensed consolidated statements of cash flows for the nine months ended September 30, 2013 and 2012 , have been reviewed by our independent registered public accountants. The review is described more fully in their report included herein. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2012 (the “ 2012 10-K”).

2013 Segment realignment and presentation change
In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. For more information on this presentation change see Note 19.
FMC Peroxygens Divestiture
In July 2013 our FMC Peroxygens segment was classified as a discontinued operation. For more information on the discontinued operations see Note 10.
We have recast all the data within this filing to reflect the changes in our reportable segments to conform to the current year presentation and to present FMC Peroxygens segment as a discontinued operation retrospectively for all periods presented.

Note 2: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items
Accounting guidance and regulatory items adopted in 2013
Reclassification from Accumulated Other Comprehensive Income
In February 2013, the Financial Accounting Standards Board ("FASB") issued its guidance requiring new disclosures for the reclassification from accumulated other comprehensive income (AOCI) to net income. This new guidance requires that we present either in a single note or parenthetically on the face of the financial statements, the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source and the income statement line items affected by the reclassification. We adopted this new guidance effective on January 1, 2013. Upon adoption, we decided to present the required disclosures in a new footnote to our condensed consolidated financial statement. For the new disclosures refer to the Reclassifications of Accumulated Other Comprehensive Income footnote, see Note 14.
Balance Sheet - Offsetting
In December 2011, the FASB issued its updated guidance on balance sheet offsetting. This new standard provides guidance to determine when offsetting in the balance sheet is appropriate. The guidance is designed to enhance disclosures by requiring improved information about financial instruments and derivative instruments. The goal is to provide users of the financial statements the ability to evaluate the effect or potential effect of netting arrangements on an entity's statement of financial position. We adopted this new guidance on January 1, 2013. The adoption of this guidance resulted in additional disclosure included within our Financial Instruments, Risk Management and Fair Value Measurements footnote, see Note 17.



8

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Note 3: Acquisitions

2013 Acquisitions
Epax:
In July 2013, we acquired 100 percent of the stock of Epax Nutra Holding III AS and Epax UK Holding III AS (together, “Epax”). Epax is a global supplier of fish-based omega-3 EPA/DHA fatty acid concentrates. Epax will be integrated into our newly formed FMC Health and Nutrition segment from the acquisition date. The acquisition of Epax is an important step in fulfilling our strategic intent to broaden our product and customer base within our Health and Nutrition segment.
The results of operations related to Epax have been included in our results since the acquisition date. This acquisition was considered a business under the U.S. GAAP business combinations accounting guidance, and therefore we applied acquisition accounting. Acquisition accounting requires, among other things, that assets and liabilities assumed be recognized at their fair values as of the acquisition date. The net assets of the Epax acquisition were recorded at the estimated fair values using primarily Level 2 and Level 3 inputs (see Note 17 for an explanation of Level 2 and 3 inputs). In valuing acquired assets and liabilities, valuation inputs include an estimate of future cash flows and discount rates based on the internal rate of return and the weighted average rate of return. Transaction-related costs were expensed as incurred and recorded to "Selling, general and administrative expenses" within our condensed consolidated statements of income.
The purchase price and related allocation is not considered final primarily due to working capital adjustments expected to occur in the fourth quarter of 2013. This may result in additional adjustments to the preliminary purchase price allocation. We will finalize the amounts recognized once we obtain the information necessary to complete the analysis, but no later than one year from the acquisition date.
Preliminary Purchase Price Allocation
(in Millions)
 
Trade receivables
$
15.6

Inventories (1)
53.7

Other current assets
4.7

Property, plant & equipment
138.3

Intangible assets (2)
71.2

Goodwill (3)
109.8

Other assets
0.6

Total fair value of assets acquired
393.9

 
 
Current liabilities
12.9

Deferred tax liabilities
41.0

Other liabilities
0.4

Total fair value of liabilities assumed
54.3

 
 
Total cash paid, less cash acquired
$
339.6

____________________ 
(1)
Fair value of finished good inventories acquired included a step-up in the value of approximately $9.1 million , which will be expensed to "Cost of sales and services" in 2013 and early 2014.
(2)
See Note 4 for the major classes of intangible assets acquired, which primarily represent customer relationships and trade names. The weighted average useful life of the acquired finite-lived intangibles is approximately 17 years .
(3)
Goodwill largely consisted of expected revenue synergies resulting from the business combinations. None of the acquired goodwill will be deductible for income tax purposes.

Unaudited pro forma revenue and net income related to the Epax acquisition is not presented because the pro forma impact is not material for prior periods.
In the first quarter of 2013 we completed the purchase of additional ownership interest in FMC Wyoming. See Note 13 for more information.

9

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

2012 Acquisitions

We completed three acquisitions during 2012. These acquisitions and related disclosures are described in more detail in Note 3 to the consolidated financial statements included in our 2012 Form 10-K. During the nine months ended September 30, 2013, we made $2.1 million of adjustments to the preliminary purchase price allocations associated with these acquisitions. These adjustments were made primarily as a result of working capital adjustments that were finalized during the first quarter 2013, however did not result in any changes to previously established goodwill balances.

Note 4: Goodwill and Intangible Assets
The changes in the carrying amount of goodwill by business segment for the nine months ended September 30, 2013 , are presented in the table below:
(in Millions)
FMC Agricultural
Solutions
 
FMC Health and Nutrition
 
Total
Balance, December 31, 2012
$
31.0

 
$
246.6

 
$
277.6

Acquisitions
—

 
109.8

 
109.8

Foreign currency adjustments
—

 
8.6

 
8.6

Balance, September 30, 2013
$
31.0

 
$
365.0

 
$
396.0

Our intangible assets, other than goodwill, consist of the following:
 
September 30, 2013
 
December 31, 2012
(in Millions)
Gross
 
Accumulated Amortization
 
Net
 
Gross
 
Accumulated Amortization
 
Net
Intangible assets subject to amortization (finite-lived)
Customer relationships
$
157.0

 
$
(13.0
)
 
$
144.0

 
$
126.6

 
$
(8.1
)
 
$
118.5

Patents
0.4

 
—

 
0.4

 
0.4

 
—

 
0.4

Trademarks and trade names
1.2

 
(0.3
)
 
0.9

 
1.2

 
(0.1
)
 
1.1

Purchased and licensed technologies
74.8

 
(17.7
)
 
57.1

 
59.1

 
(14.0
)
 
45.1

Other intangibles
4.1

 
(2.6
)
 
1.5

 
4.1

 
(1.9
)
 
2.2

 
$
237.5

 
$
(33.6
)
 
$
203.9

 
$
191.4

 
$
(24.1
)
 
$
167.3

Intangible assets not subject to amortization (indefinite life)
Trademarks and trade names
$
66.3

 
$
—

 
$
66.3

 
$
36.3

 
$
—

 
$
36.3

In-process research & development
2.1

 
—

 
2.1

 
2.1

 
—

 
2.1

 
$
68.4

 
$
—

 
$
68.4

 
$
38.4

 
$
—

 
$
38.4

Total intangible assets
$
305.9

 
$
(33.6
)
 
$
272.3

 
$
229.8

 
$
(24.1
)
 
$
205.7

At September 30, 2013 , the finite-lived and indefinite life intangibles were allocated among our business segments as follows:
(in Millions)
Finite-lived
 
Indefinite Life
FMC Agricultural Solutions
$
109.2

 
$
35.2

FMC Health and Nutrition
93.5

 
33.2

FMC Minerals
1.2

 
—

Total
$
203.9

 
$
68.4



10

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Note 5: Inventories
Inventories consisted of the following:
 (in Millions)
September 30, 2013
 
December 31, 2012
Finished goods and work in process
$
420.3

 
$
400.3

Raw materials
287.4

 
242.1

Net inventory
$
707.7

 
$
642.4



Note 6: Property, Plant and Equipment
Property, plant and equipment consisted of the following:
(in Millions)
September 30, 2013
 
December 31, 2012
Property, plant and equipment
$
2,649.4

 
$
2,417.8

Accumulated depreciation
1,485.9

 
1,461.6

Property, plant and equipment, net
$
1,163.5

 
$
956.2


Note 7: Restructuring and Other Charges (Income)
Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below:
 
Three Months Ended September 30
 
Nine Months Ended September 30
(in Millions)
2013
 
2012
 
2013
 
2012
Restructuring charges and asset disposals
$
0.5

 
$
0.1

 
$
12.2

 
$
1.8

Other charges (income), net
31.6

 
5.4

 
35.1

 
7.3

Total Restructuring and Other Charges
$
32.1

 
$
5.5

 
$
47.3

 
$
9.1



11

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

RESTRUCTURING CHARGES AND ASSET DISPOSALS

For further detail on the restructuring charges and asset disposals which commenced prior to 2013, see Note 7 to our consolidated financial statements included with our 2012 Form 10-K.
 
Restructuring Charges
 
 
 
 
(in Millions)
Severance and Employee Benefits (1)
 
Other Charges (Income) (2)
 
Asset Disposal Charges (3)
 
Total
Lithium Restructuring
(0.4
)
 
0.8

 
—

 
0.4

Other Items
—

 
0.1

 
—

 
0.1

Three months ended September 30, 2013
$
(0.4
)
 
$
0.9

 
$
—

 
$
0.5

Other Items
—

 
0.1

 
—

 
0.1

Three months ended September 30, 2012
$
—

 
$
0.1

 
$
—

 
$
0.1

 
 
 
 
 
 
 
 
Lithium Restructuring
3.3

 
4.4

 
2.0

 
9.7

Other Items
1.8

 
0.7

 
—

 
2.5

Nine months ended September 30, 2013
$
5.1

 
$
5.1

 
$
2.0

 
$
12.2

Other Items
(0.2
)
 
0.2

 
1.8

 
1.8

Nine months ended September 30, 2012
$
(0.2
)
 
$
0.2

 
$
1.8

 
$
1.8

____________________ 
(1)
Represents severance and employee benefit charges. Income represents adjustments to previously recorded severance and employee benefits.
(2)
Primarily represents costs associated with accrued lease payments, contract terminations, and other miscellaneous exit costs. Other Income primarily represents favorable developments on previously recorded exit costs as well as recoveries associated with restructurings.
(3)
Primarily represents accelerated depreciation and impairment charges on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns are also included within the asset disposal charges, see Note 8.

Roll forward of Restructuring Reserves
The following table shows a roll forward of restructuring reserves, continuing and discontinued, that will result in cash spending. These amounts exclude asset retirement obligations, which are discussed in Note 8.
(in Millions)
Balance at
12/31/12 (4)
 
Change in
reserves (2)
 
Cash
payments
 
Other (3)
 
Balance at
9/30/13 (4)
Lithium Restructuring
$
—

 
$
7.7

 
$
(6.3
)
 
$
—

 
$
1.4

Other Workforce Related and Facility Shutdowns (1)
3.1

 
2.5

 
(2.5
)
 
—

 
3.1

Restructuring activities related to discontinued operations (5)
7.4

 
1.1

 
(3.9
)
 
0.1

 
4.7

Total
$
10.5

 
$
11.3

 
$
(12.7
)
 
$
0.1

 
$
9.2

____________________ 
(1)
Primarily severance costs related to workforce reductions and facility shutdowns noted in the “Other Items” sections above.
(2)
Primarily severance, exited lease, contract termination and other miscellaneous exit costs. The accelerated depreciation and impairment charges noted above impacted our property, plant and equipment balances and are not included in the above tables.
(3)
Primarily foreign currency translation adjustments.
(4)
Included in “Accrued and other liabilities” on the condensed consolidated balance sheets.
(5)
Cash spending associated with restructuring activities of discontinued operations is reported within Payments of other discontinued reserves, net of recoveries on the condensed consolidated statements of cash flows.

12

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

OTHER CHARGES (INCOME), NET
 
Three Months Ended September 30
 
Nine Months Ended September 30
(in Millions)
2013
 
2012
 
2013
 
2012
Environmental charges, net
$
1.0

 
$
1.0

 
$
3.0

 
$
3.5

Other, net
30.6

 
4.4

 
32.1

 
3.8

Other Charges (Income), Net
$
31.6

 
$
5.4

 
$
35.1

 
$
7.3

Environmental Charges, Net
Environmental charges represent the net charges associated with environmental remediation at continuing operating sites, see Note 11 for additional details.
Other, net
During the three and nine months ended September 30, 2013 and 2012, respectively our FMC Agricultural Solutions segment entered into several collaboration and license agreements with various third-party companies for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. Further, during the three months ended September 30, 2013, we entered into three such transactions in our Agricultural Solutions segment, consisting of: exclusive license and supply arrangements for broad-spectrum crop protection products and an acquisition of certain intellectual property and other assets relating to biological products associated with our acquired assets of the Center for Agricultural and Environmental Biosolutions (CAEB). CAEB is based in Research Triangle Park, NC, and amounts acquired include CAEB’s robust library of microorganisms and a pipeline of biological products in various stages of development. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

Note 8: Asset Retirement Obligations
As of September 30, 2013 , the balance of our asset retirement obligations was $21.1 million compared to $25.5 million at December 31, 2012 . A more complete description of our asset retirement obligations can be found in Note 8 to our 2012 consolidated financial statements in our 2012 10-K.

Note 9: Debt
Debt maturing within one year:
Debt maturing within one year consists of the following:
(in Millions)
September 30, 2013
 
December 31, 2012
Short-term foreign debt (1)
$
23.1

 
$
49.9

Commercial paper
896.0

 
—

Total short-term debt
919.1

 
49.9

Current portion of long-term debt
23.3

 
5.7

Short-term debt and current portion of long-term debt
$
942.4

 
$
55.6

____________________
(1)     We often provide parent-company guarantees to lending institutions that extend credit to our foreign subsidiaries.
Commercial Paper
In June 2013, we commenced a $1.5 billion commercial paper program supported by our Credit Facility. This program allows the Company to borrow at rates generally more favorable that those available under our Credit Facility. The Company has used proceeds from the commercial paper program for general corporate purposes. At September 30, 2013, the average effective interest rate on these borrowings was 0.35% .



13

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Credit Facility
On August 5, 2013, we entered into an Amendment and Consent No. 1 (the Amendment) to our credit agreement, dated August 5, 2011. The Amendment, among other things, extended the termination date of the Credit Facility to August 5, 2017 from August 5, 2016.
Long-term debt:
Long-term debt consists of the following:
(in Millions)
September 30, 2013
 
 
 
 
Interest Rate
Percentage
 
Maturity
Date
 
9/30/2013
 
12/31/2012
Pollution control and industrial revenue bonds (less unamortized discounts of $0.2 and $0.2, respectively)
0.1-6.5%


2013-2035

$
176.7


$
176.7

Senior notes (less unamortized discount of $1.7 and $1.8, respectively)
3.95-5.2%


2019-2022

598.3


598.2

Credit Facility (1)
1.1
%
 
2017
 
—

 
130.0

Foreign debt
0-8.9%


2013-2023

20.1


9.6

Total long-term debt




$
795.1


$
914.5

Less: debt maturing within one year




23.3


5.7

Total long-term debt, less current portion




$
771.8


$
908.8

____________________
(1)
Letters of credit outstanding under our Credit Facility totaled $73.0 million and available funds under this facility were $530.8 million at September 30, 2013 (which reflects borrowings under our commercial paper program).
Covenants
Among other restrictions, our Credit Facility contains financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended September 30, 2013 , was 2.3 which is below the maximum leverage of 3.5 . Our actual interest coverage for the four consecutive quarters ended September 30, 2013 , was 17.7 which is above the minimum interest coverage of 3.5 . We were in compliance with all covenants at September 30, 2013 .

Note 10: Discontinued Operations
FMC Peroxygens:
In April 2013, the Board of Directors authorized management to pursue the sale of our FMC Peroxygens segment. In the third quarter of 2013 we concluded the sale to be probable and expect it to be completed within one year. Therefore, our FMC Peroxygens segment has been classified as a discontinued operation and as an asset held for sale.

14

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

The operating results of our FMC Peroxygens segment classified as discontinued operations are summarized below:
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
$
81.9

 
$
80.5

 
$
244.8

 
$
253.9

Income from discontinued operations before income taxes (1)
7.8

 
5.8

 
15.1

 
18.2

Provision for income taxes
3.3

 
3.5

 
7.1

 
10.0

Discontinued operations of FMC Peroxygens, net of income taxes, before divestiture related costs (2)
$
4.5

 
$
2.3

 
$
8.0

 
$
8.2

Divestiture related costs of discontinued operations of FMC Peroxygens, net of income taxes
(1.3
)
 
—

 
(2.3
)
 
—

Adjustment to assets held for sale, net of income taxes (3)
(50.8
)
 
—

 
(50.8
)
 
—

Total Discontinued operations of FMC Peroxygens, net of income taxes
$
(47.6
)
 
$
2.3

 
$
(45.1
)
 
$
8.2

____________________
(1)
Includes allocated interest expense $1.1 million and $3.5 million for the three and nine months ended September 30, 2013 and $1.2 million and $3.5 million for the three and nine months ended September 30, 2012, respectively. Interest was allocated in accordance with relevant discontinued operations accounting guidance.
(2)
In accordance with the held for sale accounting criteria effective July 2013 we stopped amortizing and depreciating all assets classified as held for sale.
(3)
GAAP accounting rules require that assets held for sale be reported at the lower of carrying value or fair value less costs to sell. The rules require that the carrying value include any accumulated foreign currency translation adjustments ("CTA") that would be reclassified to earnings upon completion of sale. Our wholly-owned Spanish subsidiary, Foret, has significant accumulated CTA losses and due in large part to the inclusion of these translation losses in our carrying value assessment, we recorded an impairment charge of approximately $65.0 million ( $50.8 million after tax).
The following table presents the major classes of assets and liabilities of discontinued FMC Peroxygens segment classified as held for sale and included as part of a disposal group in the Condensed Consolidated Balance Sheets:
(in Millions)
September 30, 2013
 
December 31, 2012
Assets
 
 
 
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)
$
96.5

 
$
92.4

Property, plant & equipment
136.6

 
180.0

Goodwill
—

 
16.9

Intangible assets, net
6.7

 
9.9

Other non-current assets
44.3

 
37.4

Noncurrent assets of discontinued operations held for sale (1)
187.6

 
244.2

Total Assets
284.1

 
336.6

 
 
 
 
Liabilities
 
 
 
Current liabilities of discontinued operations held for sale
42.3

 
54.1

Noncurrent liabilities of discontinued operations held for sale (1)
4.1

 
3.3

Total Liabilities
46.4

 
57.4

Net Assets (2)
$
237.7

 
$
279.2

____________________
(1) Presented as "Current assets\liabilities of discontinued operations held for sale" on the condensed and consolidated balance sheet as of September 30, 2013.
(2) Excludes the accumulated CTA losses of our wholly-owned Spanish subsidiary, Foret.

15

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

In addition to our discontinued FMC Peroxygens segment our other discontinued operations include adjustments to retained liabilities. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Our discontinued operations comprised the following:
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Adjustment for workers’ compensation, product liability, and other postretirement benefits, net of income tax expense of zero and $0.1 for the three and nine months ended 2013 and $0.1 and $0.2 for the three and nine months ended 2012, respectively
$
0.2

 
$
0.2

 
$
0.3

 
$
0.4

Provision for environmental liabilities, net of recoveries, net of income tax benefit of $1.2 and $3.7 for the three and nine months ended 2013 and $1.5 and $6.0 for the three and nine months ended 2012, respectively (1)
(2.0
)
 
(2.4
)
 
(6.1
)
 
(9.9
)
Provision for legal reserves and expenses, net of recoveries, net of income tax benefit of $2.7 and $2.3 for the three and nine months ended 2013 and $2.5 and $7.6 for the three and nine months ended 2012, respectively (2)
(4.4
)
 
(4.1
)
 
(3.7
)
 
(12.3
)
Provision for restructuring charges, net of income tax benefit (expense) of $0.1 and $0.4 for the three and nine months ended 2013 and ($1.3) and ($1.3) for the three and nine months ended 2012, respectively (3)
(2.8
)
 
(7.2
)
 
(3.7
)
 
(11.1
)
Discontinued operations of FMC Peroxygens, net of income tax benefit (expense) of $11.7 and $8.4 for the three and nine months ended 2013 and ($3.5) and ($10.0) for the three and nine months ended 2012, respectively
(47.6
)
 
2.3

 
(45.1
)
 
8.2

Discontinued operations, net of income taxes
$
(56.6
)
 
$
(11.2
)
 
$
(58.3
)
 
$
(24.7
)
____________________
(1)
See a roll forward of our environmental reserves as well as discussion on significant environmental issues that occurred during the 2013 in Note 11.
(2)
Discontinued operations for the nine months ended September 30, 2013, includes a gain of $13.9 million associated with an insurance recovery related to previously discontinued operations legal matters. No such gain existed in 2012.
(3)
See roll forward of our restructuring reserves in Note 7.

Note 11: Environmental Obligations
We have reserves for potential environmental obligations, which management consider probable and for which a reasonable estimate of the obligation could be made. Accordingly, we have reserves of $209.7 million and $236.5 million , excluding recoveries, at September 30, 2013 and December 31, 2012 , respectively.
The estimated reasonably possible environmental loss contingencies, net of expected recoveries, exceed amounts accrued by approximately $160 million at September 30, 2013 . This reasonably possible estimate is based upon information available as of the date of the filing but the actual future losses may be higher given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of potentially responsible parties, technology and information related to individual sites. Potential environmental obligations that have not been reserved may be material to any one quarter's or year's results of operations in the future. However, we believe any such liability arising from such potential environmental obligations is not likely to have a material adverse effect on our liquidity or financial condition as it may be satisfied over many years.

16

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

The table below is a roll forward of our total environmental reserves, continuing and discontinued:
 
(in Millions)
Operating and
Discontinued
Sites Total
Total environmental reserves, net of recoveries at December 31, 2012
$
216.0

 

Provision
14.5

Spending, net of recoveries
(38.7
)
Net change
(24.2
)
Total environmental reserves, net of recoveries at September 30, 2013
$
191.8

Environmental reserves, current, net of recoveries  (1)
27.5

Environmental reserves, long-term continuing and discontinued, net of recoveries (2)
164.3

Total environmental reserves, net of recoveries at September 30, 2013
$
191.8

____________________
(1)
“Current” includes only those reserves related to continuing operations. These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.
(2)
These amounts are included in “Environmental liabilities, continuing and discontinued” on the condensed consolidated balance sheets.
At September 30, 2013 and December 31, 2012 , we have recorded recoveries representing probable realization of claims against U.S. government agencies, insurance carriers and other third parties. Recoveries are recorded as either an offset to the “Environmental liabilities, continuing and discontinued” or as “Other assets” in the condensed consolidated balance sheets. The table below is a roll forward of our total recorded recoveries from December 31, 2012 to September 30, 2013 :
(in Millions)
12/31/2012
 
Increase in Recoveries
 
Cash Received
 
9/30/2013
Environmental liabilities, continuing and discontinued
$
20.5

 
$
0.8

 
$
(3.4
)
 
$
17.9

Other assets
51.6

 
1.8

 
(15.2
)
 
38.2

Total
$
72.1

 
2.6

 
$
(18.6
)
 
$
56.1


Our net environmental provisions relate to costs for the continued cleanup of both operating sites and for certain discontinued manufacturing operations from previous years. The net provisions are comprised as follows:
 
Three Months Ended September 30
 
Nine Months Ended September 30
(in Millions)
2013
 
2012
 
2013
 
2012
Continuing operations (1)
$
1.0

 
$
1.0

 
$
3.0

 
$
3.5

Discontinued operations (2)
3.2

 
3.9

 
9.7

 
15.9

Net environmental provision
$
4.2

 
$
4.9

 
$
12.7

 
$
19.4

____________________
(1) Recorded as a component of “Restructuring and other charges (income)” on our condensed consolidated statements of income. See Note 7.
(2) Recorded as a component of “Discontinued operations, net of income taxes" on our condensed consolidated statements of income. See Note 10.


17

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

On our condensed consolidated balance sheets, the net environmental provisions are recorded to the following balance sheet captions:
 
Three Months Ended September 30
 
Nine Months Ended September 30
(in Millions)
2013
 
2012
 
2013
 
2012
Environmental reserves (1)
$
4.2

 
$
4.9

 
$
14.5

 
$
19.4

Other assets (2)
—

 
—

 
(1.8
)
 
—

Net environmental provision
$
4.2

 
$
4.9

 
$
12.7

 
$
19.4

____________________
(1)     See above roll forward of our total environmental reserves as presented on our condensed consolidated balance sheets.
(2)     Represents certain environmental recoveries.

A more complete description of our environmental contingencies and the nature of our potential obligations are included in Notes 1 and 10 to our consolidated financial statements in our 2012 Form 10-K. The following represents significant updates that occurred in 2013 related to these contingencies.
Pocatello
The Tribal Appellate Court with respect to the appeal regarding our Pocatello site has scheduled an evidentiary hearing for the fourth quarter of 2013 on certain jurisdictional issues. The Tribes have filed additional litigation to recover the permit fees for the years since 2007, but that litigation has been stayed pending the outcome of the appeal in the Tribal Court of Appeals. A more complete description of our environmental contingencies, the Pocatello legal matter and the nature of our potential obligations are included in Notes 1 and 10 to our consolidated financial statements in our 2012 Form 10-K.
Middleport
During the second quarter 2013 we received from the United States Environmental Protection Agency and New York State Department of Environmental Conservation, collectively the “Agencies”, the Final Statement of Basis (FSOB). This FSOB is consistent with the Preliminary Statement of Basis (PSOB) previously received from Agencies in June 2012. The FSOB includes the same Corrective Action Management Alternative (“CMA”) as the PSOB. We continue to believe that the CMA is overly conservative and not supported under New York State law. In order to negotiate with the Agencies with respect to the CMA, we entered into a tolling agreement with the Agencies. The tolling agreement serves as a “standstill” agreement to the FSOB so that time spent negotiating with the Agencies does not go against the statute of limitations under the FSOB.
The amount of the reserve for this site is $40.4 million at September 30, 2013 and $42.4 million at December 31, 2012. Our reserve continues to include the estimated liability for clean-up to reflect the costs associated with our recommended CMA. Our estimated reasonably possible environmental loss contingencies exposure reflects the additional cost of the CMA proposed in the FSOB. A more complete description of our environmental contingencies pertaining to our Middleport environmental site, is included in Note 10 to our consolidated financial statements in our 2012 Form 10-K.

Note 12: Earnings Per Share
Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period on a basic and diluted basis.
Our potentially dilutive securities include potential common shares related to our stock options, restricted stock and restricted stock units. Diluted earnings per share (“Diluted EPS”) considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an antidilutive effect. Diluted EPS excludes the impact of potential common shares related to our stock options in periods in which the option exercise price is greater than the average market price of our common stock for the period. There were no potential common shares excluded from Diluted EPS for the three and nine months ended September 30, 2013 and 2012. As further discussed in Note 13, our accelerated share repurchase program had no impact on Diluted EPS for the three and nine months ended September 30, 2013 .
Our non-vested restricted stock awards contain rights to receive non-forfeitable dividends, and thus, are participating securities requiring the two-class method of computing EPS. The two-class method determines EPS by dividing the sum of distributed earnings to common stockholders and undistributed earnings allocated to common stockholders by the weighted average number of shares of common stock outstanding for the period. In calculating the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the weighted average number of shares outstanding during the period.

18

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Earnings applicable to common stock and common stock shares used in the calculation of basic and diluted earnings per share are as follows:
(in Millions, Except Share and Per Share Data)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Earnings (loss) attributable to FMC stockholders:
 
 
 
 
 
 
 
Income from continuing operations attributable to FMC stockholders
$
74.5

 
$
101.2

 
$
325.1

 
$
338.7

Discontinued operations, net of income taxes
(56.6
)
 
(11.2
)
 
(58.3
)
 
(24.7
)
Net income
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

Less: Distributed and undistributed earnings allocable to restricted award holders
(0.2
)
 
(0.4
)
 
(1.1
)
 
(1.5
)
Net income allocable to common stockholders
$
17.7

 
$
89.6

 
$
265.7

 
$
312.5

 
 
 
 
 
 
 
 
Basic earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
Continuing operations
$
0.55

 
$
0.73

 
$
2.39

 
$
2.45

Discontinued operations
(0.42
)
 
(0.08
)
 
(0.43
)
 
(0.18
)
Net income
$
0.13

 
$
0.65

 
$
1.96

 
$
2.27

 
 
 
 
 
 
 
 
Diluted earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
Continuing operations
$
0.55

 
$
0.73

 
$
2.38

 
$
2.44

Discontinued operations
(0.42
)
 
(0.08
)
 
(0.43
)
 
(0.18
)
Net income
$
0.13

 
$
0.65

 
$
1.95

 
$
2.26

 
 
 
 
 
 
 
 
Shares (in thousands):
 
 
 
 
 
 
 
Weighted average number of shares of common stock outstanding - Basic
134,146

 
137,373

 
135,779

 
137,731

Weighted average additional shares assuming conversion of potential common shares
816

 
1,015

 
921

 
1,123

Shares – diluted basis
134,962

 
138,388

 
136,700

 
138,854



19

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Note 13: Equity
Refer to the table below for a reconciliation of equity, equity attributable to the parent, and equity attributable to noncontrolling interests for the nine months ended September 30, 2013 :  
(in Millions, Except Per Share Data)
FMC’s
Stockholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
Balance at December 31, 2012
$
1,480.3

 
$
74.5

 
$
1,554.8

Net income
266.8

 
9.3

 
276.1

Stock compensation plans
23.1

 
—

 
23.1

Excess tax benefits from share-based compensation
6.7

 
—

 
6.7

Shares for benefit plan trust
0.6

 
—

 
0.6

Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax (1)
27.5

 
—

 
27.5

Net hedging gains/(losses) and other, net of income tax (1)
(5.0
)
 
—

 
(5.0
)
Foreign currency translation adjustments (1)
1.0

 
0.4

 
1.4

Dividends ($0.405 per share)
(55.1
)
 
—

 
(55.1
)
Repurchases of common stock
(316.6
)
 
—

 
(316.6
)
Accelerated share repurchase program (2)
(50.0
)
 
—

 
(50.0
)
Acquisition of noncontrolling interests (3)
(55.2
)
 
(24.8
)
 
(80.0
)
Distributions to noncontrolling interests
—

 
(9.9
)
 
(9.9
)
Balance at September 30, 2013
$
1,324.1

 
$
49.5

 
$
1,373.6

____________________
(1)
See condensed consolidated statements of comprehensive income.
(2)
See accelerated share repurchase program discussion below.
(3)
See "FMC Wyoming" discussion below.

FMC Wyoming
We purchased an additional 6.25 percent ownership interest in FMC Wyoming Corporation (FMC WY) in March 2013 from Nippon Sheet Glass Company Ltd. for $80.0 million which increased our ownership from 87.50 percent to 93.75 percent . FMC WY is our majority owned joint venture that manufactures, markets and sells soda ash products. The seller of the 6.25 percent interest was one of two noncontrolling interest holders of FMC WY stock.
Dividends and Share Repurchases
For the nine months ended September 30, 2013 and 2012 , we paid $55.6 million and $35.4 million , respectively, in dividends declared in previous periods. On October 17, 2013 , we paid dividends totaling $18.1 million to our shareholders of record as of September 30, 2013 . This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2013 .
 
During the nine months ended September 30, 2013 , we repurchased 4,998,843 shares under the publicly announced repurchase program for $309.9 million .

On April 23, 2013 our Board authorized the repurchase of up to $500 million of our common shares. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. The authorization of April 23, 2013, replaced the previous authority under which $134.9 million was unused. At September 30, 2013 , $250 million remained unused under our Board-authorized repurchase program.

Accelerated share repurchase program
In July 2013, we entered into an accelerated share repurchase program ("ASR") and paid $250.0 million to a financial institution for an initial delivery of approximately 3.2 million shares, which reduced our shares outstanding at July 31, 2013. The shares will be acquired under our previously announced $500 million share repurchase program. The value of the initial shares received on

20

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

the date of purchase was $200 million , reflecting a $63.58 price per share which was recorded as a treasury share purchase for purposes of calculating earnings per share. We recorded the remaining $50.0 million as a forward contract indexed to our common stock in capital in excess of par value of common stock on our condensed and consolidated balance sheet.
As of September 30, 2013, we evaluated the ASR for its potential dilution of earnings per share and have determined that, based on the volume weighed average price of our common stock calculated through September 30, 2013, there is no dilutive impact on earnings per share. The total amount of shares to be ultimately delivered by the financial institution will be determined by the average price per share paid by the financial institution during the purchase period. Final settlement of the ASR is expected to be completed by year end, but may be completed sooner under certain circumstances.

Note 14: Reclassifications of Accumulated Other Comprehensive Income

The table below provides details about the reclassifications from Accumulated Other Comprehensive Income and the affected line items in the condensed consolidated statements of income for each of the periods presented.
Details about Accumulated Other Comprehensive Income Components
 
Amounts Reclassified from Accumulated Other Comprehensive Income  (1)
 
Affected Line Item in the Condensed Consolidated Statements of Income
 
 
Three Months Ended September 30
 
Nine Months Ended September 30
 
 
(in Millions)
 
2013
 
2012
 
2013
 
2012
 
 
Derivative instruments:
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$
0.3

 
$
2.1

 
$
0.7

 
$
9.1

 
Costs of sales and services
Energy contracts
 
(0.4
)
 
(2.3
)
 
(0.2
)
 
(8.6
)
 
Costs of sales and services
Foreign currency contracts
 
(1.5
)
 
(3.8
)
 
1.1

 
(7.1
)
 
Selling, general and administrative expenses
Other contracts
 
—

 
—

 
(0.1
)
 
(0.1
)
 
Interest expense, net
 
 
$
(1.6
)
 
$
(4.0
)
 
1.5

 
(6.7
)
 
Total before tax
 
 
0.4

 
1.4

 
(0.6
)
 
2.5

 
Income tax (expense) benefit
 
 
$
(1.2
)
 
$
(2.6
)
 
0.9

 
(4.2
)
 
Amount included in net income
 
 
 
 
 
 
 
 
 
 
 
Pension and other postretirement benefits (2) :
 
 
 
 
 
 
 
 
 
 
Amortization of prior service costs
 
$
(0.5
)
 
$
(0.4
)
 
$
(1.5
)
 
$
(1.4
)
 
Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses)
 
(2.7
)
 
(10.8
)
 
(36.2
)
 
(35.3
)
 
Selling, general and administrative expenses
Recognized loss due to settlement
 
$
(7.1
)
 
$
—

 
$
(7.1
)
 
$
—

 
Selling, general and administrative expenses
 
 
$
(10.3
)
 
$
(11.2
)
 
$
(44.8
)
 
$
(36.7
)
 
Total before tax
 
 
4.1

 
4.8

 
17.1

 
14.5

 
Income tax (expense) benefit
 
 
$
(6.2
)
 
$
(6.4
)
 
$
(27.7
)
 
$
(22.2
)
 
Amount included in net income
 
 
 
 
 
 
 
 
 
 
 
Total reclassifications for the period
 
$
(7.4
)
 
$
(9.0
)
 
$
(26.8
)
 
$
(26.4
)
 
Amount included in net income
____________________
(1)
Amounts in parentheses indicate charges to the condensed consolidated statements of income.
(2)
Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 15.



21

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Note 15: Pensions and Other Postretirement Benefits
The following table summarizes the components of net annual benefit cost (income) for the three and nine months ended September 30, 2013 and 2012 :
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
Pensions
 
Other Benefits
 
Pensions
 
Other Benefits
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Components of net annual benefit cost (income):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost
$
5.8

 
$
5.1

 
$
—

 
$
—

 
$
16.6

 
$
15.2

 
$
—

 
$
0.1

Interest cost
14.3

 
15.6

 
0.2

 
0.4

 
42.3

 
46.1

 
0.8

 
1.0

Expected return on plan assets
(19.1
)
 
(19.0
)
 
—

 
—

 
(57.5
)
 
(57.4
)
 
—

 
—

Amortization of prior service cost (credit)
0.6

 
0.4

 
—

 
—

 
1.7

 
1.5

 
—

 
(0.1
)
Recognized net actuarial and other (gain) loss
3.8

 
11.9

 
(0.6
)
 
(0.8
)
 
38.8

 
38.4

 
(1.5
)
 
(1.8
)
Recognized loss due to settlement (1)
7.1

 
—

 
—

 
—

 
7.1

 
—

 
—

 
—

Net periodic benefit cost from continuing operations
$
12.5

 
$
14.0

 
$
(0.4
)
 
$
(0.4
)
 
$
49.0

 
$
43.8

 
$
(0.7
)
 
$
(0.8
)
____________________
(1)
Settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives.
We made voluntary cash contributions to our U.S. defined benefit pension plan of $40.0 million and $65.0 million in the nine months ended September 30, 2013 and September 30, 2012. We do not expect to make any additional voluntary cash contributions to the plan for 2013.

Note 16: Income Taxes
Provision for income taxes was $32.0 million resulting in an effective tax rate of 29.5 percent compared to a provision of $29.9 million resulting in an effective tax rate of 22.0 percent for the three months ended September 30, 2013 and 2012 , respectively. The change in the effective tax rate was primarily impacted by the mix of income among subsidiaries and tax charges associated with the expected sale of our discontinued FMC Peroxygens segments discussed below.
Provision for income taxes was $113.1 million resulting in an effective tax rate of 25.3 percent compared to a provision of $113.2 million resulting in an effective tax rate of 24.2 percent for the nine months ended September 30, 2013 and 2012 , respectively. The change in the effective tax rate was consistent with the change in the three months ended September 30, 2013, as discussed in the previous paragraph.
In the third quarter of 2013, we changed our assertion on unremitted earnings for certain foreign subsidiaries as a result of our expected sale of our discontinued FMC Peroxygens segment. Therefore, as of September 30, 2013, we provided deferred tax liabilities of approximately $4.0 million attributable to taxable temporary differences from those unremitted earnings and the intended repatriation of proceeds earned on the sale. We have not provided income taxes on our equity of undistributed earnings of our other foreign subsidiaries or affiliates since our intention remains that such earnings will be permanently reinvested.

Note 17: Financial Instruments, Risk Management and Fair Value Measurements
Our financial instruments include cash and cash equivalents, trade receivables, other current assets, certain receivables classified as other long-term assets, accounts payable, and amounts included in investments and accruals meeting the definition of financial instruments. The carrying value of these financial instruments approximates their fair value. Our other financial instruments include the following:
Financial Instrument
  
Valuation Method
Foreign exchange forward contracts
  
Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.
 
 
 
Commodity forward and option contracts
  
Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices for applicable commodities.
 
 
 
Debt
  
Our estimates and information obtained from independent third parties using market data, such as bid/ask spreads for the last business day of the reporting period.

22

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)


The estimated fair value of the financial instruments in the above table have been determined using standard pricing models which take into account the present value of expected future cash flows discounted to the balance sheet date. These standard pricing models utilize inputs derived from or corroborated by observable market data such as interest rate yield curves and currency and commodity spot and forward rates. In addition, we test a subset of our valuations against valuations received from the transaction's counterparty to validate the accuracy of our standard pricing models. Accordingly, the estimates presented may not be indicative of the amounts that we would realize in a market exchange at settlement date and do not represent potential gains or losses on these agreements. The estimated fair values of foreign exchange forward contracts and commodity forward and option contracts are included in the tables within this Note. The estimated fair value of debt is $1,774.7 million and $1,057.0 million and the carrying amount is $1,714.2 million and $964.4 million as of September 30, 2013 and December 31, 2012 , respectively.
We enter into various financial instruments with off-balance-sheet risk as part of the normal course of business. These off-balance-sheet instruments include financial guarantees and contractual commitments to extend financial guarantees under letters of credit, and other assistance to customers (Note 18). Decisions to extend financial guarantees to customers, and the amount of collateral required under these guarantees is based on our evaluation of creditworthiness on a case-by-case basis.
Use of Derivative Financial Instruments to Manage Risk
We mitigate certain financial exposures, including currency risk, commodity purchase exposures and interest rate risk, through a program of risk management that includes the use of derivative financial instruments. A detailed description of these risks including a discussion on the concentration of credit risk is provided in Note 17 to our consolidated financial statements on our 2012 Form 10-K.
We formally document all relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also assess both, at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If we determine that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we discontinue hedge accounting with respect to that derivative prospectively.
Accounting for Derivative Instruments and Hedging Activities
Cash Flow Hedges
We recognize all derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, we generally designate the derivative as a hedge of the variability of cash flows to be received or paid related to a forecasted transaction (cash flow hedge). We record in AOCI changes in the fair value of derivatives that are designated as and meet all the required criteria for a cash flow hedge. We then reclassify these amounts into earnings as the underlying hedged item affects earnings. In contrast, we immediately record in earnings changes in the fair value of derivatives that are not designated as cash flow hedges.
As of September 30, 2013 , we had open foreign currency forward contracts in AOCI in a net after tax loss position of $4.5 million designated as cash flow hedges of underlying forecasted sales and purchases. Current open contracts hedge forecasted transactions until December 31, 2014. At September 30, 2013 , we had open forward contracts designated as cash flow hedges with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $468.7 million .
As of September 30, 2013 , we had current open commodity contracts in AOCI in a net after tax loss position of $0.8 million designated as cash flow hedges of underlying forecasted purchases, primarily related to natural gas. Current open commodity contracts hedge forecasted transactions until December 31, 2014. At September 30, 2013 , we had 6.2 million mmBTUs (millions of British Thermal Units) in aggregate notional volume of outstanding natural gas commodity forward contracts to hedge forecasted purchases.
Of the $5.3 million of net losses after-tax, representing both open foreign currency exchange contracts and commodity contracts, approximately $4.2 million of these losses would be realized in earnings during the twelve months ending September 30, 2014 and $1.1 million of net losses will be realized subsequent to September 30, 2014, if spot rates in the future are consistent with forward rates as of September 30, 2013 . The actual effect on earnings will be dependent on the actual spot rates when the forecasted transactions occur. We recognize derivative gains and losses in the “Costs of sales and services” line in the condensed consolidated statements of income.
 
Derivatives Not Designated As Hedging Instruments
We hold certain forward contracts that have not been designated as cash flow hedging instruments for accounting purposes. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as cash flow hedging instruments, and changes in the fair value of these items are recorded in earnings. We

23

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

occasionally hold call options that are effective as economic hedges of a portion of our natural gas exposure and the change in fair value of this instrument is also recorded in earnings. We periodically hold soybean barter contracts which qualify as derivatives and we have entered into offsetting commodity contracts to hedge our exposure. Both the change in fair value of the soybean barter contracts and the offsetting commodity contracts are recorded in earnings.
We had open forward contracts not designated as cash flow hedging instruments for accounting purposes with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $873.0 million at September 30, 2013 . We held an immaterial amount of bushels, in aggregate notional volume of outstanding soybean contracts, to hedge outstanding barter contracts at September 30, 2013 .

Fair Value of Derivative Instruments
The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments as of September 30, 2013 and December 31, 2012 .
 
September 30, 2013
 
Gross Amount of Derivatives
 
 
 
 
 
 
(in Millions)
Designated as Cash Flow Hedges
 
Not Designated as Hedging Instruments
 
Total Gross Amounts
 
Gross Amounts Offset in the Consolidated Balance Sheet (3)
 
Net Amounts
Derivatives
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
5.3

 
$
0.7

 
$
6.0

 
$
(5.9
)
 
$
0.1

Energy contracts
0.2

 
—

 
0.2

 
(0.2
)
 
—

Other contracts
0.1

 
—

 
0.1

 
—

 
0.1

Total derivative assets  (1)
$
5.6

 
$
0.7

 
$
6.3

 
$
(6.1
)
 
$
0.2

 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(12.1
)
 
$
(4.5
)
 
$
(16.6
)
 
$
5.9

 
$
(10.7
)
Energy contracts
(1.6
)
 
—

 
(1.6
)
 
0.2

 
(1.4
)
Total derivative liabilities  (2)
$
(13.7
)
 
$
(4.5
)
 
$
(18.2
)
 
$
6.1

 
$
(12.1
)
 
 
 
 
 
 
 
 
 
 
Net derivative assets/(liabilities)
$
(8.1
)
 
$
(3.8
)
 
$
(11.9
)
 
$
—

 
$
(11.9
)
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012
 
Gross Amount of Derivatives
 
 
(in Millions)
Designated as Cash Flow Hedges
 
Not Designated as Hedging Instruments
 
Gross Amounts
 
Gross Amounts Offset in the Consolidated Balance Sheet (3)
 
Net Amounts
Derivatives
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
5.7

 
$
—

 
$
5.7

 
$
(4.2
)
 
$
1.5

Energy contracts
0.2

 
—

 
0.2

 
(0.2
)
 
—

Other contracts
0.2

 
—

 
0.2

 
—

 
0.2

Total derivative assets  (1)
$
6.1

 
$
—

 
$
6.1

 
$
(4.4
)
 
$
1.7

 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(4.7
)
 
$
(1.9
)
 
$
(6.6
)
 
$
4.2

 
$
(2.4
)
Energy contracts
(1.7
)
 
—

 
(1.7
)
 
0.2

 
(1.5
)
Total derivative liabilities  (2)
$
(6.4
)
 
$
(1.9
)
 
$
(8.3
)
 
$
4.4

 
$
(3.9
)
 
 
 
 
 
 
 
 
 
 
Net derivative assets/(liabilities)
$
(0.3
)
 
$
(1.9
)
 
$
(2.2
)
 
$
—

 
$
(2.2
)
____________________
(1)
Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.
(2)
Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.
(3)
Represents net derivatives positions subject to master netting arrangements.



24

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)


The tables below summarizes the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments for the three and nine months ended September 30, 2013 and 2012 .

Derivatives in Cash Flow Hedging Relationships

 
Three Months Ended September 30
 
Contracts
 
 
 
 
 
Foreign Exchange
 
Energy
 
Other
 
Total
(in Millions)
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Unrealized hedging gains (losses) and other, net of tax
$
(0.9
)
 
$
(0.1
)
 
$
—

 
$
1.2

 
$
—

 
$
—

 
$
(0.9
)
 
$
1.1

Reclassification of deferred hedging (gains) losses, net of tax (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective portion
0.8

 
1.0

 
0.3

 
1.4

 
0.2

 
0.1

 
1.3

 
2.5

Ineffective portion
(0.1
)
 
0.1

 
—

 
—

 
—

 
—

 
(0.1
)
 
0.1

Total derivative instrument impact on comprehensive income
$
(0.2
)
 
$
1.0

 
$
0.3

 
$
2.6

 
$
0.2

 
$
0.1

 
$
0.3

 
$
3.7

 
 
Nine Months Ended September 30
 
Contracts
 
 
 
 
 
Foreign Exchange
 
Energy
 
Other
 
Total
(in Millions)
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Unrealized hedging gains (losses) and other, net of tax
$
(4.1
)
 
$
1.0

 
$
—

 
$
(0.6
)
 
$
—

 
$
—

 
$
(4.1
)
 
$
0.4

Reclassification of deferred hedging (gains) losses, net of tax  (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective portion
(1.0
)
 
(1.3
)
 
0.2

 
5.4

 
0.1

 
0.1

 
(0.7
)
 
4.2

Ineffective portion
(0.2
)
 
—

 
—

 
—

 
—

 
—

 
(0.2
)
 
—

Total derivative instrument gain (loss)
$
(5.3
)
 
$
(0.3
)
 
$
0.2

 
$
4.8

 
$
0.1

 
$
0.1

 
$
(5.0
)
 
$
4.6

____________________
(1)
See Note 14 for classification of amounts within the condensed consolidated statements of income.


Derivatives Not Designated as Hedging Instruments
 
 
Location of Gain or (Loss)
Recognized in Income on Derivatives
Amount of Pre-tax Gain or (Loss) 
Recognized in Income on Derivatives
 
 
Three Months Ended September 30
 
Nine Months Ended September 30
(in Millions)
 
2013
 
2012
 
2013
 
2012
Foreign exchange contracts
Cost of sales and services
$
8.8

 
$
(8.2
)
 
$
6.3


$
11.1

Total
 
$
8.8

 
$
(8.2
)
 
$
6.3

 
$
11.1




25

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Fair-Value Measurements
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are defined as buyers or sellers in the principle or most advantageous market for the asset or liability that are independent of the reporting entity, knowledgeable and able and willing to transact for the asset or liability.

Fair-Value Hierarchy
We have categorized our assets and liabilities that are recorded at fair value, based on the priority of the inputs to the valuation technique, into a three-level fair-value hierarchy. The fair-value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets and liabilities fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair-value measurement of the instrument.

Recurring Fair Value Measurements
The following tables present our fair-value hierarchy for those assets and liabilities measured at fair-value on a recurring basis in our condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012 . During the periods presented there were no transfers between fair-value hierarchy levels.
 
(in Millions)
September 30, 2013
 
Quoted
Prices
in  Active
Markets  for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Derivatives – Commodities (1) :
 
 
 
 
 
 
 
Other contracts
$
0.1

 
$
—

 
$
0.1

 
$
—

Derivatives – Foreign exchange  (1)
0.1

 
—

 
0.1

 
—

Other  (2)
33.4

 
33.4

 
—

 
—

Total assets
$
33.6

 
$
33.4

 
$
0.2

 
$
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Derivatives – Commodities  (1) :
 
 
 
 
 
 
 
Energy contracts
$
1.4

 
$
—

 
$
1.4

 
$
—

Derivatives – Foreign exchange (1)
10.7

 
—

 
10.7

 
—

Acquisition (3)
0.5

 
—

 
—

 
0.5

Other  (4)
38.1

 
38.1

 
—

 
—

Total liabilities
$
50.7

 
$
38.1

 
$
12.1

 
$
0.5

  ____________________
(1)
See the Fair Value of Derivative Instruments table within this Note for classifications on our condensed consolidated balance sheet.
(2)
Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.
(3)
Represents contingent consideration associated with acquisitions completed during 2011. The changes in this Level 3 liability represented payments made against the liability.
(4)
Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts due are included in “Other long-term liabilities” in the condensed consolidated balance sheets.

26

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

(in Millions)
December 31, 2012
 
Quoted
Prices
in  Active
Markets  for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Derivatives – Commodities  (1) :
 
 
 
 
 
 
 
Other contracts
$
0.2

 
$
—

 
$
0.2

 
$
—

Derivatives – Foreign exchange (1)
1.5

 
—

 
1.5

 
—

Other  (2)
33.0

 
33.0

 
—

 
—

Total assets
$
34.7

 
$
33.0

 
$
1.7

 
$
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Derivatives – Commodities (1) :
 
 
 
 
 
 
 
Energy contracts
$
1.5

 
$
—

 
$
1.5

 
$
—

Derivatives – Foreign exchange  (1)
2.4

 
—

 
2.4

 
—

Acquisition   (3)
1.0

 
—

 
—

 
1.0

Other (4)
39.8

 
39.8

 
—

 
—

Total liabilities
$
44.7

 
$
39.8

 
$
3.9

 
$
1.0

____________________
(1)
See the Fair Value of Derivative Instruments table within this Note for classification on our condensed consolidated balance sheet.
(2)
Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.
(3)
Represents contingent consideration associated with acquisitions completed during 2011. The changes in this Level 3 liability represented payments made against the liability.
(4)
Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts included in “Other long-term liabilities” in the condensed consolidated balance sheets.

Nonrecurring Fair Value Measurements
The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a non-recurring basis in our condensed consolidated balance sheets during the nine months ended September 30, 2013 and the year ended December 31, 2012 .
(in Millions)
September 30, 2013
 
Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total Gains (Losses) (Nine Months Ended September 30, 2013)
Assets
 
 
 
 
 
 
 
 
 
Net assets of discontinued operations held for sale (1)
$
237.7

 
$
—

 
$
—

 
$
237.7

 
$
(65.0
)
Long-lived assets associated with exit activities  (2)
$
2.6

 
$
—

 
$
—

 
$
2.6

 
$
(2.0
)
Total assets
$
240.3

 
$
—

 
$
—

 
$
240.3

 
$
(67.0
)
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
Liabilities associated with exit activities (3)
$
—

 
$
—

 
$
—

 
$
—

 
$
(7.7
)
Total liabilities
$
—

 
$
—

 
$
—

 
$
—

 
$
(7.7
)
____________________
(1)
As further discussed in Note 10, we assessed the carrying value of the net assets held for sale of our discontinued FMC Peroxygens segment at September 30, 2013. The charge was recorded in "Discontinued operations, net of income taxes" for the three months ended September 30, 2013. Our evaluation of fair value, less cost to sell included using a combination of preliminary bids received from prospective buyers, discounted cash flow models, and other valuation models, such as

27

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

comparative transactions and market multiples, to estimate the fair value. The value of "net assets of discontinued operations held for sale" in the table above excludes the accumulated CTA losses of our wholly-owned Spanish subsidiary, Foret, which were included in our fair value less cost to sell evaluation.
(2)
We recorded charges, within our FMC Minerals segment, to write down the value of certain long-lived assets to their fair value related to our Lithium restructuring. A portion of the assets were written down to zero during the first quarter of 2013 as they have no future use and are anticipated to be demolished.
(3)
This amount represents severance liabilities associated with the Lithium restructuring as further described in Note 7.

(in Millions)
December 31, 2012
 
Quoted
Prices
in  Active
Markets  for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total Gains
(Losses)
(Year Ended
December 31,
2012)
Assets
 
 
 
 
 
 
 
 
 
Long-lived assets to be abandoned  (1)
$
3.1

 
$
—

 
$
—

 
$
3.1

 
$
(15.9
)
Total assets
$
3.1

 
$
—

 
$
—

 
$
3.1

 
$
(15.9
)
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
Liabilities associated with exit activities (2)
5.6

 
—

 
5.6

 
—

 
(5.6
)
Total liabilities
$
5.6

 
$
—

 
$
5.6

 
$
—

 
$
(5.6
)
____________________
(1)
We recorded charges to write down the value of certain long-lived assets to be abandoned within our FMC Agricultural Solutions and FMC Minerals segments to zero and in our discontinued FMC Peroxygens segments to their salvage value of $3.1 million , respectively. These long-lived assets have no future use and are anticipated to be demolished. The loss noted in the above table represents the accelerated depreciation of these assets recorded during the period.
(2)
This amount represents severance liabilities associated with the Zeolites shutdown within our discontinued FMC Peroxygens segment.

Note 18: Guarantees, Commitments, and Contingencies
We continue to monitor the conditions that are subject to guarantees and indemnifications to identify whether a liability must be recognized in our financial statements.
Guarantees and Other Commitments
The following table provides the estimated undiscounted amount of potential future payments for each major group of guarantees at September 30, 2013 :  
(in Millions)
 
Guarantees:
 
Guarantees of vendor financing
$
21.3

Foreign equity method investment debt guarantees
8.5

Other debt guarantees
17.0

Total
$
46.8

We provide guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers, principally in Brazil and Mexico, for their seasonal borrowing. The total of these guarantees was $21.3 million and $31.4 million at September 30, 2013 and December 31, 2012 , respectively, and are recorded on the condensed consolidated balance sheets for each date as “Guarantees of vendor financing”. The change in the guarantees is generally due to the seasonality of the FMC Agricultural Solutions business.





28

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

Excluded from the chart above, in connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale. Our indemnification obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum or maximum individual or aggregate claim amounts. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover some of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.
Contingencies

Competition / antitrust litigation related to the discontinued FMC Peroxygens segment . We are subject to actions brought by private plaintiffs relating to alleged violations of European and Canadian competition and antitrust laws, as further described below.
European competition action. Multiple European purchasers of hydrogen peroxide who claim to have been harmed as a result of alleged violations of European competition law by hydrogen peroxide producers assigned their legal claims to a single entity formed by a law firm. The single entity then filed a lawsuit in Germany in March 2009 against European producers, including our wholly-owned Spanish subsidiary, Foret. Initial defense briefs were filed in April 2010, and an initial hearing was held during the first quarter of 2011, at which time case management issues were discussed. At a subsequent hearing in October 2011, the Court indicated that it was considering seeking guidance from the European Court of Justice (“ECJ”) as to whether the German courts have jurisdiction over these claims. After submission of written comments on this issue by the parties, on March 1, 2012, the judge announced that she would refer the jurisdictional issues to the ECJ. The court issued its formal reference to the ECJ on April 29, 2013. Such a referral to the ECJ normally takes 12-18 months for completion after the formal reference. Since the case is in the preliminary stages and is based on a novel procedure - namely the attempt to create a cross-border “class action” which is not a recognized proceeding under EU or German law - we are unable to develop a reasonable estimate of our potential exposure of loss at this time. We intend to vigorously defend this matter.
Canadian antitrust actions. In 2005, after public disclosures of the U.S. federal grand jury investigation into the hydrogen peroxide industry (which resulted in no charges brought against us) and the filing of various class actions in U.S. federal and state courts, which have all been settled, putative class actions against us and five other major hydrogen peroxide producers were filed in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. The other five defendants have settled these claims for a total of approximately $20.6 million . On September 28, 2009, the Ontario Superior Court of Justice certified a class of direct and indirect purchasers of hydrogen peroxide from 1994 to 2005. Our motion for leave to appeal the class certification decision was denied in June 2010. Since then, the case has been largely dormant. In early 2012 the parties began a more detailed dialogue on discovery and at a hearing on April 5, 2012, they requested the judge to issue more specific guidance on document production. The court instead stayed the litigation pending resolution by the Canadian Supreme Court of the viability of indirect purchaser claims. The Canadian Supreme Court heard argument on that issue in October 2012. Since the proceedings are in the preliminary stages with respect to the merits, we are unable to develop a reasonable estimate of our potential exposure of loss at this time. We intend to vigorously defend these matters.
Asbestos claims. Like hundreds of other industrial companies, we have been named as one of many defendants in asbestos-related personal injury litigation. Most of these cases allege personal injury or death resulting from exposure to asbestos in premises of FMC or to asbestos-containing components installed in machinery or equipment manufactured or sold by businesses classified as discontinued operations. We intend to continue managing these cases in accordance with our historical experience. We have established a reserve for this litigation within our discontinued operations and are unable to develop a reasonable estimate of any exposure of a loss in excess of the established reserve. Our experience has been that the overall trends in terms of the rate of filing of asbestos-related claims with respect to all potential defendants has changed over time, and that filing rates as to us in particular have varied significantly over the last several years. We are a peripheral defendant - that is, we have never manufactured asbestos or asbestos-containing components. As a result, claim filing rates against us have yet to form a predictable pattern, and we are unable to project a reasonably accurate future filing rate and thus, we are presently unable to reasonably estimate our asbestos liability with respect to claims that may be filed in the future.
Other contingent liabilities. In addition to the matters disclosed above, we have certain other contingent liabilities arising from litigation, claims, products we have sold, guarantees or warranties we have made, contracts we have entered into, indemnities we have provided, and other commitments incident to the ordinary course of business. Some of these contingencies are known - for example pending product liability litigation or claims - but are so preliminary that the merits cannot be determined, or if more advanced, are not deemed material based on current knowledge; and some are unknown - for example, claims with respect to

29

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

which we have no notice or claims which may arise in the future, resulting from products we have sold, guarantees or warranties we have made, or indemnities we have provided. Therefore, we are unable to develop a reasonable estimate of our potential exposure of loss for these contingencies, either individually or in the aggregate, at this time. Based on information currently available and established reserves, we have no reason to believe that the ultimate resolution of our known contingencies, including the matters described in this Note, will have a material adverse effect on our consolidated financial position, liquidity or results of operations. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations in any one reporting period, or liquidity.
See Note 11 for the Pocatello tribal litigation for a legal proceeding associated with our environmental contingencies.

Note 19: Segment Information  
In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. The new segments better reflect the markets where we participate and lead today, and where we expect to grow in the future. As a result of this decision the following changes were made:
•
Our BioPolymer division has been moved into a standalone reporting segment and renamed FMC Health and Nutrition. This change better reflects our strategic intent to continue to broaden our product and customer base in faster growing food and pharmaceutical segments and to expand into nutraceuticals, personal care and similar markets.
•
We have combined our Lithium and Alkali Chemicals divisions into a single reporting segment, FMC Minerals. We believe doing this will enable us to leverage technical resources and improve operating performance in both businesses.
•
Our Agricultural Products Group has been renamed FMC Agricultural Solutions. We believe this name change better reflects the value-added solutions and services that we provide to our customers.
•
Finally, our Peroxygens and related Environmental Solutions product lines became a standalone reporting segment called FMC Peroxygens. During the second quarter of 2013 we began the process of marketing the segment for sale. In July 2013, we classified the FMC Peroxygens segment as a discontinued operation and asset held for sale. For more information on this presentation change see Note 10.
Additionally, effective in January 2013, our segment presentations including allocation of certain corporate expenses were updated to reflect how we currently make financial decisions and allocate resources. The presentation change was also made since we believe the changes provide a better understanding of the underlying profitability of each individual business segment. The changes were the following:
•
Allocation of certain long-term incentives, primarily stock-based compensation, from the category other income (expense), net to each business segment.
•
Allocation of the depreciation on capitalized interest associated with completed construction projects from the category other income (expense), net to each business segment.
•
The presentation of the impact of noncontrolling interest as its own line item. Noncontrolling interest impacts were previously netted within each individual segment. The majority of the noncontrolling interest pertains to our FMC Minerals segment.
•
We have combined other income (expense), net and corporate expense into one line item renamed “Corporate and other”.
We have recast the data below to reflect the above changes in our reportable segments to conform to the current year presentation and to present FMC Peroxygens segment as a discontinued operation retrospectively for all periods presented.


30

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (unaudited)—(Continued)

(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
530.2

 
$
423.6

 
$
1,468.0

 
$
1,271.4

FMC Health and Nutrition
190.4

 
173.7

 
572.2

 
512.7

FMC Minerals
237.8

 
224.6

 
706.8

 
710.3

Eliminations
(1.0
)
 
—

 
(2.9
)
 
—

Total
$
957.4

 
$
821.9

 
$
2,744.1

 
$
2,494.4

Income from continuing operations before income taxes
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
114.2

 
$
100.9

 
$
402.2

 
$
343.7

FMC Health and Nutrition
41.1

 
40.3

 
129.1

 
126.0

FMC Minerals
27.7

 
34.6

 
92.1

 
127.1

Eliminations
(0.1
)
 
0.1

 
(0.3
)
 
0.1

Segment operating profit
182.9

 
175.9

 
623.1

 
596.9

Corporate and other
(20.1
)
 
(16.2
)
 
(60.2
)
 
(56.6
)
Operating profit before the items listed below
162.8

 
159.7

 
562.9

 
540.3

Restructuring and other (charges) income (1)
(32.1
)
 
(5.5
)
 
(47.3
)
 
(9.1
)
Interest expense, net
(9.8
)
 
(9.8
)
 
(31.4
)
 
(30.3
)
Non-operating pension and postretirement (charges) income (2)
(5.7
)
 
(8.1
)
 
(30.0
)
 
(26.3
)
Acquisition related charges  (3)
(6.7
)
 
(0.6
)
 
(6.7
)
 
(7.2
)
Provision for income taxes
(32.0
)
 
(29.9
)
 
(113.1
)
 
(113.2
)
Discontinued operations, net of income taxes
(56.6
)
 
(11.2
)
 
(58.3
)
 
(24.7
)
Net income attributable to noncontrolling interests
$
(2.0
)
 
$
(4.6
)
 
$
(9.3
)
 
$
(15.5
)
Net income attributable to FMC stockholders
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

_________________________________________
(1)
See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended September 30, 2013 , relate to FMC Agricultural Solutions of $30.7 million , FMC Health and Nutrition of $0.1 million , FMC Minerals of $0.3 million and Corporate of $1.0 million . Amounts for the three months ended September 30, 2012 , relate to FMC Agricultural Solutions of $4.4 million , FMC Health and Nutrition of $0.1 million and Corporate of $1.0 million . Amounts for the nine months ended September 30, 2013 , related to FMC Agricultural Solutions of $32.6 million , FMC Health and Nutrition of $0.8 million , FMC Minerals of $9.6 million and Corporate of $4.3 million . Amounts for the nine months ended September 30, 2012 , related to FMC Agricultural Solutions of $6.1 million , FMC Health and Nutrition of $0.3 million , FMC Minerals of $(0.3) million and Corporate $3.0 million .
(2)
Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.
(3)
Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and certain professional fees associated the completion of acquisitions. Charges for the three and nine months ended September 30, 2013, represented amortization of inventory fair value step-up of $2.1 million and certain professional fees of $4.6 million associated with the completion of our Epax acquisition within our FMC Health and Nutrition segment. The charges for the three and nine month periods ended September 30, 2012, representing amortization of inventory fair value step-up relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses".


31

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.
Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2012 (the “ 2012 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.
We further caution that the list of risk factors in Item 1A in Part I of the 2012 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2012 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.
The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2012 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.
•
Environmental obligations and related recoveries
•
Impairment and valuation of long-lived assets
•
Pensions and other postretirement benefits
•
Income taxes
We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.
RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS
See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.


32
Table of Contents

OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. The FMC Health and Nutrition segment focuses on food ingredients that are used to enhance texture, color, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications and ultrapure biopolymers for medical devices. Our FMC Minerals segment manufactures a wide range of inorganic materials including soda ash and lithium. Soda ash is utilized in markets such as glass and detergents and lithium utilized in energy storage, specialty polymers and pharmaceutical synthesis in industrial uses.
Beginning with the third quarter 2013 our FMC Peroxygens segment has been accounted for as a discontinued operation. Prior period information has been recasted. For additional information on discontinued operations, refer to Note 10 in our notes to the condensed consolidated financial statements within this Form 10-Q.

Third Quarter 2013 Highlights

The following are the more significant developments in our businesses during the three months ended September 30, 2013 :
•
Revenue of $957.4 million for the three months ended September 30, 2013 increased $135.5 million or 16 percent versus the same period last year. Revenue increases are associated with sales growth in all segments. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations" . On a regional basis, sales in Latin America increased by 29 percent, sales in North America were up 11 percent, sales in Asia were up six percent and sales in Europe, Middle East and Africa increased by eight percent.
•
Our gross margin, excluding acquisition related charges, increased by approximately $8 million or approximately three percent to $306.5 million versus last year's third quarter driven by higher volumes and pricing primarily in our FMC Agricultural Solutions segment partially offset by unfavorable foreign currency impacts. Gross margin percent of 32 percent declined from 36 percent, primarily as a result of unfavorable geographic mix of sales in FMC Agricultural Solutions and the aforementioned unfavorable currency impacts.
•
Selling, general and administrative expenses, excluding non-operating pension and postretirement charges and acquisition/divestiture related charges, increased by approximately $4 million or four percent to $114.6 million. The increase period over period is largely due to increased spending on targeted growth initiatives to meet the growth in our business. The majority of these increases were experienced in our FMC Agricultural Solutions segment.
•
Research and Development expenses of $29.0 million increased $0.9 million or three percent.
•
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $110.2 million increased $3.1 million or three percent primarily due to higher operating results in FMC Agricultural Solutions, slightly offset by a higher effective tax rate. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations" .
•
In July 2013, we acquired Epax Nutra Holding III AS and Epax UK Holding III AS (together, “Epax”). Epax is a global supplier of fish-based omega-3 EPA/DHA fatty acid concentrates. Epax will be integrated into our newly formed FMC Health and Nutrition segment from the acquisition date. The acquisition of Epax is an important step in fulfilling our strategic intent to broaden our product and customer base within our Health and Nutrition segment.
•
In August 2013,  we concluded a licensing agreement with Belchim Crop Protection for access to valifenalate, a fungicide which will be introduced into our Agricultural Solutions segment. Our rights are exclusive for use in mixtures in the Americas as well as select countries in Asia. The product is already registered and sold in certain countries in Latin America, and we plan to register in many other countries in our territory.
•
In late September and early October 2013, we entered into two separate transactions that together provide our Agricultural Solutions segment with a strong foundation for developing, manufacturing and marketing biologically-based products to enhance yields and respond to evolving pest pressures and resistance. Namely, we acquired the assets of the Center for Agricultural and Environmental Biosolutions (CAEB), based in Research Triangle Park, NC, including CAEB’s robust library of microorganisms and a pipeline of biological products in various stages of development. Further, in October 2013, we entered into an exclusive collaboration with Chr. Hansen A/S, a leading global biosciences company with expertise in screening, fermentation, and scale up of microbially-based products.   Together with Agricultural Solutions’

33
Table of Contents

existing capabilities, we believe these transactions establish FMC as an industry leader in the growing market for biologically-based agricultural products.


34
Table of Contents

RESULTS OF OPERATIONS
Overview
The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).
SEGMENT RESULTS RECONCILIATION
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
530.2

 
$
423.6

 
$
1,468.0

 
$
1,271.4

FMC Health and Nutrition
190.4

 
173.7

 
572.2

 
512.7

FMC Minerals
237.8

 
224.6

 
706.8

 
710.3

Eliminations
(1.0
)
 
—

 
(2.9
)
 
—

Total
$
957.4

 
$
821.9

 
$
2,744.1

 
$
2,494.4

Income (loss) from continuing operations before income taxes
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
114.2

 
$
100.9

 
$
402.2

 
$
343.7

FMC Health and Nutrition
41.1

 
40.3

 
129.1

 
126.0

FMC Minerals
27.7

 
34.6

 
92.1

 
127.1

Eliminations
(0.1
)
 
0.1

 
(0.3
)
 
0.1

Segment operating profit
182.9

 
175.9

 
$
623.1

 
$
596.9

Corporate and other
(20.1
)
 
(16.2
)
 
(60.2
)
 
(56.6
)
Operating profit before the items listed below
162.8

 
159.7

 
562.9

 
540.3

 
 
 
 
 
 
 
 
Interest expense, net
(9.8
)
 
(9.8
)
 
(31.4
)
 
(30.3
)
Corporate special (charges) income:
 
 
 
 
 
 
 
Restructuring and other (charges) income
(32.1
)
 
(5.5
)
 
(47.3
)
 
(9.1
)
Non-operating pension and postretirement charges (1)
(5.7
)
 
(8.1
)
 
(30.0
)
 
(26.3
)
Acquisition related charges (2)
(6.7
)
 
(0.6
)
 
(6.7
)
 
(7.2
)
Provision for income taxes
(32.0
)
 
(29.9
)
 
(113.1
)
 
(113.2
)
Discontinued operations, net of income taxes
(56.6
)
 
(11.2
)
 
(58.3
)
 
(24.7
)
Net income attributable to noncontrolling interests
(2.0
)
 
(4.6
)
 
(9.3
)
 
(15.5
)
Net income attributable to FMC stockholders
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

____________________
(1)
Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.
(2)
Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and costs incurred associated the completion of acquisitions. Charges for the three and nine months ended September 30, 2013, represented amortization of inventory fair value step-up and professional fees associated with the completion of our Epax acquisition within our FMC Health and Nutrition segment. The charges for the three and nine month periods ended September 30, 2012 relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses".

35
Table of Contents

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, acquisition/divestiture related charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.
ADJUSTED EARNINGS RECONCILIATION
(in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Net income attributable to FMC stockholders (GAAP)
$
17.9

 
$
90.0

 
$
266.8

 
$
314.0

Corporate special charges (income), pre-tax
44.5

 
14.2

 
84.0

 
42.6

Income tax expense (benefit) on Corporate special charges (income)
(16.2
)
 
(5.3
)
 
(31.1
)
 
(15.9
)
Corporate special charges (income), net of income taxes
28.3

 
8.9

 
52.9

 
26.7

Discontinued operations, net of income taxes
56.6

 
11.2

 
58.3

 
24.7

Tax adjustments
7.4

 
(3.0
)
 
9.1

 
(1.9
)
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)
$
110.2

 
$
107.1

 
$
387.1

 
$
363.5

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.
Segment Results
For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition/divestiture related charges, and other income and expense items.
Information about how some of these items relate to our businesses at the segment level is discussed in Note 19 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our consolidated financial statements in our 2012 Form 10-K.
In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. The new segments better reflect the markets where we participate and lead today, and where we expect to grow in the future. Also, beginning in the third quarter of 2013, our FMC Peroxygens segment has been accounted for as a discontinued operation.
For more information on these presentation changes see Notes 10 and 19 to our condensed consolidated financial statements included within this Form 10-Q.
The Segment Results as discussed below for all periods presented have been updated to reflect the presentation change and reporting of FMC Peroxygens as a discontinued operation.

36
Table of Contents

FMC Agricultural Solutions
 
($ in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
$
530.2

 
$
423.6

 
1,468.0

 
1,271.4

Operating Profit
114.2

 
100.9

 
402.2

 
343.7


Three Months Ended September 30, 2013 vs. 2012
Revenue of $530.2 million increased approximately 25 percent versus the prior year quarter due to sales growth in Latin America, North America and Asia offset by declines in Europe/Middle East/Africa ("EMEA").
Latin America sales of $359.3 million increased 34 percent due primarily to Brazil reflecting strong market conditions, increased planted area for key crops, volume growth in herbicide and insecticide sales for soybeans and growth from new and recently introduced product. North America sales of $67.5 million increased 22 percent driven by strong demand for herbicides partially offset by weaker pest pressures compared to last year that reduced rescue insecticide demand. Revenue in Asia of $75.2 million increased 13 percent reflecting sales growth in Australia, India, China and Thailand markets. EMEA declined 17 percent to $28.2 million primarily due to lower insecticide sales.
FMC Agricultural Solutions' operating profit of $114.2 million increased approximately 13 percent compared to the year-ago quarter, reflecting the sales growth described in the preceding paragraph, impacted by geographic mix and unfavorable currency impact. Selling, general and administrative costs were approximately $3 million higher compared to the prior year due to increased spending on growth initiatives and higher people-related costs.
Nine Months Ended September 30, 2013 vs. 2012
Revenue of $1,468.0 million increased approximately 15 percent versus the prior year period due to sales growth in North America, Latin America and Asia, partially offset by declines in EMEA.
Sales in Latin America of $698.6 million increased 14 percent driven by Brazil volume growth in herbicide and insecticide sales for soybeans, including growth from new and recently launched product. Sales in North America of $426.8 million increased 30 percent driven by strong demand for pre-emergent herbicides and at-plant insecticides as well as growth from new product introductions. Revenue in Asia of $234.3 million increased 14 percent reflecting sales growth in China, Indonesia, Australia and a number of other key countries. EMEA declined 13 percent to $108.3 million primarily due to unfavorable weather conditions and lower insecticide sales.
FMC Agricultural Solutions' operating profit of $402.2 million increased approximately 17 percent compared to the year-ago period, reflecting the sales growth described in the preceding paragraph, a favorable geographic/product mix and selected price increases. Selling, general and administrative costs were approximately $5 million higher compared to the prior year due to increased spending on growth initiatives and higher people-related costs.
In 2013, we expect full-year revenue percentage growth in the high-teens reflecting increased volumes due to strong market conditions and growth from new and recently introduced products, including new fungicides, as well as our direct market access initiatives in Asia and Latin America. We expect full-year segment operating profit to grow in the mid- to high-teens percentage, driven by sales gains partially offset by increased selling, general and administrative and research and development spending to support growth.
Certain Regulatory Issues
In 2009, our bifenthrin product was excluded from the European Commission's official list of approved pesticides. We submitted for reconsideration of that decision and in 2012 bifenthrin was re-approved for use in the European Union. FMC has submitted for registrations in EU Member States. We can resume selling bifenthrin in the European market once the registrations are approved by the Member States. With the exception of France, we expect that most registrations will be approved over the next 24 months; due to the continued inclusion of bifenthrin on the French “Grenelle” list of pesticides we cannot predict when we may regain a French registration. We believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we challenge that decision. In July 2013, the French Conseil d' Etat court dismissed our challenge. During 2013, we will not sell any bifenthrin for agricultural use into the EU, similar to the prior year, and the absence of such sales will not have a material effect on the Company's financial condition or results of operations.
We intend to defend vigorously all our products in the U.S., EU and other countries as our pesticide products are reviewed in the ordinary course of regulatory programs during 2013 as part of the ongoing cycle of re-registration of our pesticide

37
Table of Contents

products around the world. In September 2013, the Brazilian health surveillance agency informed us that they intend to review carbofuran along with six other major pesticides during 2013-14, but has yet to issue any formal announcement that identifies its specific concerns or preliminary position on re-registration. We are cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to regulatory reviews in Brazil during 2013.
FMC Health and Nutrition
 
($ in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
$
190.4

 
$
173.7

 
572.2

 
512.7

Operating Profit
41.1

 
40.3

 
129.1

 
126.0

Three Months Ended September 30, 2013 vs. 2012
Revenue was $190.4 million , an increase of approximately 10 percent versus the prior-year quarter. Revenue from acquisitions increased sales by approximately eight percent while favorable pricing and currency impacts increased sales by one percent, respectively.
Segment operating profit of $41.1 million increased two percent versus the year ago quarter as revenue growth was slightly offset by acquisition-related start up expenses, increased raw material costs, primarily seaweed, and costs to improve our manufacturing capabilities which we refer to as Manufacturing Excellence.
Nine Months Ended September 30, 2013 vs. 2012
Revenue was $572.2 million , an increase of approximately 12 percent versus the prior-year period. This increase was due to volume increases of four percent in core product lines, revenue from acquisitions which increased sales by five percent and favorable pricing and foreign currency impacts which increased sales by two and one percent, respectively.
Segment operating profit of $129.1 million increased by two percent versus the prior year period as revenue growth was partially offset by acquisition related costs, increased raw material costs and Manufacturing Excellence costs. Selling, general and administrative costs also increased approximately $1.9 million compared to the prior year due to increased spending on growth initiatives.
In 2013, we expect full-year revenue to be up mid-teens percent driven by higher volumes and contributions from acquisitions. Full-year segment operating profit are expected to grow in high single digits percent with sales gains in core segment product lines and benefits from the Epax acquisition partially offset by acquisition-related and Manufacturing Excellence costs.
FMC Minerals
 
($ in Millions)
Three Months Ended September 30
 
Nine Months Ended September 30
2013
 
2012
 
2013
 
2012
Revenue
$
237.8

 
$
224.6

 
$
706.8

 
$
710.3

Operating Profit
27.7

 
34.6

 
92.1

 
127.1

Three Months Ended September 30, 2013 vs. 2012
Revenue of $237.8 million increased by approximately six percent versus the prior-year quarter. Volume gains in both Alkali and Lithium were partially offset by unfavorable pricing in our Alkali division.
Alkali revenues of $181.2 million increased five percent as lower average export prices, particularly in Asia were more than offset by higher overall volumes.
Lithium revenues of $56.6 million increased eight percent compared to the prior year quarter. Increased volumes contributed six percent and favorable pricing added two percent to sales growth.

38
Table of Contents

Segment operating profit of $27.7 million decreased approximately 20 percent versus the year ago quarter. Operating profit was impacted by lower average export pricing, one-time production factors, and a scheduled maintenance shutdown partially by higher global soda ash sales volumes. Selling, general and administrative costs also increased approximately $1 million compared to the prior year.
Nine Months Ended September 30, 2013 vs. 2012
Revenue of $706.8 million , was essentially flat period over period. Unfavorable pricing in Alkali and volume declines in our Lithium division negatively impacted sales by four percent and two percent, respectively. These declines were offset by increased volumes and higher freight billings in Alkali which favorably impacted sales by four and two percent.
Alkali revenues of $555.1 million increased two percent over the prior year due to higher freight billings, while volume gains of five percent were completely offset by reduced pricing.
Lithium revenues of $151.7 million decreased eight percent compared to the prior year. Lithium experienced reduced volumes earlier in the year which impacted revenue by 10 percent. These volume declines were partially offset by favorable pricing and mix impacting sales by two percent. The lower volumes were due to production constraints, the effects of recent labor disputes in Chilean ports and the impact of snow blocking the Jama Pass between Argentina and Chile which provides critical access to and from Chilean ports.
Segment operating profit of $92.1 million decreased approximately 28 percent versus the prior year. The decrease is consistent with that of the three months ended September 30, 2013 noted above, which was primarily due to lower average export pricing. Selling, general and administrative costs also decreased approximately $4 million compared to the prior year due to the benefits of restructuring activities within our Lithium division.
In 2013, we expect full-year revenue percentage growth flat to up low-single percent driven primarily by volumes and higher prices in soda ash in the second half of the year as well as Lithium operational improvements in the fourth quarter. We expect full-year segment operating profit to decline by low to mid-20 percent, reflecting Lithium margin improvements offset by one-time Alkali operational challenges and lower average export soda ash prices.
Other Results of Operations
Corporate and other
Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on our condensed consolidated statements of income.
Three Months Ended September 30, 2013 vs. 2012
Corporate and other expenses of $20.1 million in the third quarter of 2013 increased by $3.9 million from $16.2 million in the same period in 2012 . The increase period over period is due to increased costs to support growth initiatives within our businesses including a transformation of our finance organization. This transformation is similar to past initiatives to improve our organization.
Nine Months Ended September 30, 2013 vs. 2012
Corporate and other expenses of $60.2 million in the nine months of 2013 increased slightly from $56.6 million in the same period in 2012 . The increase period over period is consistent with the three months ended September 30, 2013 noted above.
Interest expense, net
Three Months Ended September 30, 2013 vs. 2012
Interest expense, net for the third quarter of 2013 was $9.8 million as compared to the third quarter of 2012 of $9.8 million .
Nine Months Ended September 30, 2013 vs. 2012
Interest expense, net for the nine months ended September 30, 2013 was $31.4 million as compared to $30.3 million in 2012.


39
Table of Contents

Corporate special (charges) income
Three Months Ended September 30, 2013 vs. 2012
Restructuring and other charges (income)
These charges totaled $32.1 million in the third quarter of 2013 compared to $5.5 million in the third quarter of 2012 . Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income). See the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Restructuring and asset disposal charges in 2013 of $0.5 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $31.6 million primarily related to charges associated with collaboration and license agreements entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.
Restructuring and asset disposal charges in 2012 of $0.1 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $5.4 million were primarily related to charges associated with collaboration and license agreements entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development.
The liabilities associated with the restructuring charges listed above are also included within Note 7 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.
Non-operating pension and postretirement charges
The charge for the three months ended September 30, 2013 was $5.7 million compared to $8.1 million for the three months ended September 30, 2012 . The decrease was primarily the result of lower amortization of actuarial losses of $7.5 million attributable to a lengthening of the average remaining service period used for amortization purposes as a result of a completed actuarial study indicating overall decreases in retirement and termination activity. Lower interest costs associated with decreases in rates amounted to approximately $2.0 million of the decrease as well. Offsetting these decreases was a settlement charge of $7.1 million associated with the acceleration of previously deferred actuarial losses triggered by lump-sum payouts to former executives.  These expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income. 
Acquisition related charges
Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and certain professional fees associated the completion of acquisitions. Charges for the three and nine months ended September 30, 2013, represented amortization of inventory fair value step-up of $2.1 million and certain professional fees of $4.6 million associated with the completion of our Epax acquisition within our FMC Health and Nutrition segment. The charges for the three and nine month periods ended September 30, 2012, representing amortization of inventory fair value step-up relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses".
Nine Months Ended September 30, 2013 vs. 2012
Restructuring and other charges (income)
These charges totaled $47.3 million in the nine months ended September 30, 2013 compared to $9.1 million in 2012 . Restructuring and asset disposal charges in 2013 of $12.2 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $35.1 million were primarily related the items associated with the three months ended September 30, 2013, as discussed previously.
Restructuring and asset disposal charges in 2012 of $1.8 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $7.3 million were primarily related the items associated with the three months ended September 30, 2013, as discussed previously.

40
Table of Contents

Non-operating pension and postretirement charges
The charge for the nine months ended September 30, 2013 was $30.0 million compared to $26.3 million for the nine months ended September 30, 2012 . The increase in charges were primarily the result of a settlement charge of $7.1 million, partially offset by lower interest costs of $4.5 million.
Acquisition/divestiture related charges
Charges for the nine months ended September 30, 2013 of $6.7 million related to the items noted within the preceding three months ended September 30, 2013 discussion. Charges for the nine months ended September 30, 2012 of $7.2 million related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with acquisitions completed prior to 2012.
Provision for income taxes
Three Months Ended September 30, 2013 vs. 2012
Provision for income taxes was $32.0 million resulting in an effective tax rate of 29.5 percent compared to a provision of $29.9 million resulting in an effective tax rate of 22.0 percent for the three months ended September 30, 2013 and 2012 , respectively. The increase in the effective tax rate was primarily impacted by the mix of income among subsidiaries and tax charges associated with the expected sale of our discontinued FMC Peroxygens segment. See Note 16 to our condensed consolidated financial statements included in this Form 10-Q for more information.
Nine Months Ended September 30, 2013 vs. 2012
Provision for income taxes was $113.1 million resulting in an effective tax rate of 25.3 percent compared to a provision of $113.2 million resulting in an effective tax rate of 24.2 percent for the nine months ended September 30, 2013 and 2012 , respectively. The change period over period was impacted by the items described in the three months ended September 30, 2013, as discussed in the previous paragraph.
Discontinued operations, net of income taxes
Our discontinued operations represent our discontinued FMC Peroxygens segment results as well as adjustments to retained liabilities from previous discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Three Months Ended September 30, 2013 vs. 2012
Discontinued operations, net of income taxes represented a loss of $56.6 million for the three months ended September 30, 2013 , compared to a charge of $11.2 million for the three months ended September 30, 2012 . The increase was a result of a charge of $65.0 million ($50.8 million after tax) associated with our discontinued FMC Peroxygens segment. For more information on our discontinued operations, net of income taxes see Note 10 to our condensed consolidated financial statements included in this Form 10-Q.
Nine Months Ended September 30, 2013 vs. 2012
Discontinued operations, net of income taxes represented a loss of $58.3 million for the nine months ended September 30, 2013 , compared to a charge of $24.7 million for the nine months ended September 30, 2012 . The increase was a result of a charge of $65.0 million ($50.8 million after tax) associated with our discontinued FMC Peroxygens segment, partially offset by 2012 restructuring activity in Spain.  For more information on our discontinued operations, net of income taxes see Note 10 to our condensed consolidated financial statements included in this Form 10-Q.
Net income attributable to FMC stockholders
Three Months Ended September 30, 2013 vs. 2012
Net income attributable to FMC stockholders decreased to $17.9 million for the three months ended September 30, 2013 , from $90.0 million for the three months ended September 30, 2012 . The decrease was primarily due to charges recorded to discontinued operations associated with our discontinued FMC Peroxygens segment during the current quarter, higher restructuring and other charges and corporate and other expenses. Partially offsetting these costs are higher operating profits in FMC Agricultural Solutions.

41
Table of Contents


Nine Months Ended September 30, 2013 vs. 2012
Net income attributable to FMC stockholders decreased to $266.8 million for the nine months ended September 30, 2013 , from $314.0 million for the nine months ended September 30, 2012 . The decrease was primarily due to charges recorded to discontinued operations associated with our discontinued FMC Peroxygens segment during the third quarter 2013. This decrease was partially offset by higher operating profits in FMC Agricultural Solutions.



 

42
Table of Contents

LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents at September 30, 2013 and December 31, 2012 , were $109.6 million and $77.1 million , respectively. Of the cash and cash equivalents balance at September 30, 2013 , $90.7 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of the majority of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings. However, in the third quarter of 2013, we changed our assertion on the portion of our foreign subsidiaries unremitted earnings that we intend to repatriate upon the sale of our discontinued FMC Peroxygens segment and have recorded the taxes that would be payable upon such repatriation. In the event that additional funds from our foreign subsidiaries are repatriated to the U.S., we would be required to accrue and pay U.S. taxes on those amounts.
In June 2013, we commenced a $1.5 billion commercial paper program supported by our credit facility. This program allows the Company to borrow at rates generally more favorable that those available under our credit facility. The Company has used proceeds from the commercial paper program for general corporate purposes. At September 30, 2013, the average effective interest rate on these borrowings was 0.35% .
On August 5, 2013, we entered into an Amendment and Consent No. 1 (the "Amendment") to our credit agreement, dated as of August 5, 2011. The Amendment, among other things, extended the termination date of the credit facility to August 5, 2017 from August 5, 2016.
At September 30, 2013 , we had total debt of $1,714.2 million as compared to $964.4 million at December 31, 2012 . The increase was primarily associated with higher borrowings under our commercial paper program to support strategic growth opportunities and working capital requirements. Total debt included $771.8 million and $908.8 million of long-term debt (excluding current portions of $23.3 million and $5.7 million ) at September 30, 2013 and December 31, 2012 , respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, increased from $49.9 million at December 31, 2012 to $919.1 million at September 30, 2013 .


43
Table of Contents

Statement of Cash Flows
Cash provided (required) by operating activities was $380.6 million and $368.9 million for the nine months ended September 30, 2013 and 2012, respectively.
The table below presents the components of net cash provided (required) by operating activities.
(in Millions)
Nine Months Ended September 30
2013
 
2012
Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes
$
479.4

 
$
498.0

Significant non-cash expenses (1)
154.1

 
142.1

Operating income before non-cash expenses (Non-GAAP)
633.5

 
640.1

 
 
 
 
Change in trade receivables (2)
(93.9
)
 
(82.6
)
Change in inventories (3)
(14.0
)
 
(143.9
)
Change in accounts payable
0.6

 
3.7

Change in accrued rebates (4)
194.8

 
163.3

Change in advance payments from customers (5)
(122.1
)
 
(66.6
)
Change in all other operating assets and liabilities (6)
18.7

 
(5.2
)
Restructuring and other spending (7)
(8.8
)
 
(0.6
)
Environmental spending, continuing, net of recoveries (8)
(4.3
)
 
(4.3
)
Pension and other postretirement benefit contributions (9)
(63.1
)
 
(72.7
)
Cash basis operating income (Non-GAAP)
541.4

 
431.2

 
 
 
 
Interest payments
(29.5
)
 
(24.9
)
Tax payments
(124.6
)
 
(30.0
)
Excess tax benefits from share-based compensation
(6.7
)
 
(7.4
)
 
 
 
 
Cash provided (required) by operating activities
$
380.6

 
$
368.9

____________________ 
(1)
Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.
(2)
Overall, the use of cash for trade receivables is primarily due to revenue increases, particularly for Agricultural Solutions' sales in Brazil where terms are significantly longer than the rest of our businesses. Amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.
(3)
The change in inventory from 2012 to 2013 was due to timing of inventory build in our FMC Agricultural Solutions segment to satisfy 2013 season demand. The majority of the build to satisfy the 2013 demand occurred in the latter of 2012. Higher sales also contributed to the change year over year.
(4)
These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year. The increase from 2012 to 2013 is primarily associated with the increased sales for FMC Agricultural Solutions in North America.
(5)
The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. The use of cash for each year presented is consistent with our sales increases year over each year. We received substantial increases in advance payments from customers at the end of 2012 related to 2013 season compared to the prior period.
(6)
Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities.
(7)
See Note 7 in our condensed consolidated financial statements included in this Form 10-Q for further details.

44
Table of Contents

(8)
Included in our income for both periods presented are environmental charges of $3.0 million, respectively, for environmental remediation at our operating sites. The amounts in 2013 will be spent in periods beyond third quarter 2013. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.
(9)
Amounts include voluntary contributions to our U.S. defined benefit plan of $40.0 million and $65.0 million, respectively.
Cash required by operating activities of discontinued operations was $31.4 million and $36.3 million for the nine months ended September 30, 2013 and 2012 , respectively.
Both periods include our discontinued FMC Peroxygens segment which required cash of $5.2 million in 2013 compared to an inflow of cash of $2.2 million in the prior years. This change was due to reduced operating income period over period. Additionally, cash required by operating activities of discontinued operations includes a $13.9 million insurance recovery received during the second quarter of 2013, which did not occur in 2012. This recovery partially offset higher environmental spending related to discontinued operations during the nine months ended September 30, 2013 , compared to the prior year period.
Cash required by investing activities of continuing operations was $555.3 million and $251.3 million for the nine months ended September 30, 2013 and 2012 , respectively.
The increase in spending during the nine months ended September 30, 2013 , as compared to the same period in 2012 was primarily due to the Epax acquisition completed in third quarter of 2013 and higher spending on capital expenditures compared to 2012 to support growth initiatives.
Cash required by investing activities of discontinued operations was $15.2 million and $19.0 million for the nine months ended September 30, 2013 and 2012 , respectively.
The decrease is due to reduced spending associated with capital expenditures.
Cash provided (required) by financing activities was $253.7 million and $(137.1) million for the nine months ended September 30, 2013 and 2012 , respectively.
The change in financing activities is primarily due to borrowings under our commercial paper ("CP") program which was implemented during the second quarter of 2013. The CP borrowings were partially offset by repayments of borrowings under our committed credit facility, the acquisition of an additional 6.25% ownership interest in our consolidated entity FMC Wyoming and higher dividends paid and share repurchases compared to 2012. See Note 13 in our condensed consolidated financial statements included in this Form 10-Q for further details on the acquisition of additional ownership interest in FMC Wyoming.
Other potential liquidity needs
Our cash needs for 2013 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2013 our remaining borrowing capacity under our credit facility was $530.8 million (which include borrowings under our commercial paper program).
Our discontinued FMC Peroxygens segment is currently held for sale and we believe the sale to be completed within one year.
Projected 2013 capital expenditures as well as expenditures related to contract manufacturers are expected to be approximately 35 percent higher than 2012 levels, primarily to increase capacity in our FMC Health and Nutrition and FMC Minerals segments.
Projected 2013 spending includes approximately $40 million of net environmental remediation spending. This spending does not include expected spending of approximately $10 million associated with capital projects relating to environmental control facilities. Also, we expect to spend approximately $30 million in 2013 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.
In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through September 30, 2013 of $40.0 million . These contributions are in excess of the minimum requirements. We made voluntary contributions of $65 million in 2012. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

45
Table of Contents

For the nine months ended September 30, 2013 and 2012, we paid $55.6 million and $35.4 million , respectively, in dividends declared in previous periods. On October 17, 2013 , we paid dividends totaling $18.1 million to our shareholders of record as of September 30, 2013 . This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2013 .
On April 23, 2013 our Board-authorized the repurchase of up to $500.0 million of our common shares. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. The authorization of April 23, 2013, replaced the previous authority under which $134.9 million was unused.
During the nine months ended September 30, 2013 , we repurchased 4,998,843 shares under the publicly announced repurchase program for $309.9 million . At September 30, 2013 , $250 million remained unused under our Board-authorized repurchase program.
In July 2013, we entered into an accelerated share repurchase agreement (ASR) and paid $250.0 million to a financial institution for an initial delivery of approximately 3.2 million shares, which reduced the our shares outstanding at July 31, 2013. The repurchse is taking place under our previously announced $500.0 million share repurchase program. The value of the initial shares received on the date of purchase was $200.0 million, reflecting a $63.58 price per share which was recorded as a treasury share purchase for purposes of calculating earnings per share. We recorded the remaining $50.0 million as a forward contract indexed to our common stock in additional paid in capital. Final settlement of the ASR, corresponding to the date we will purchase the remaining $50.0 million of common stock under the ASR, is expected to be completed by year end, but may be completed sooner under certain circumstances. The final number of shares that the company is repurchasing under the ASR, the timing of the final settlement, and the aggregate cost will depend upon prevailing market conditions and the final discounted volume-weighted average share price over the term of the ASR.
The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") was signed into law in 2010. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe they will not adversely affect our liquidity in a material way.

Commitments and Contingencies
See Note 18 to our condensed consolidated financial statements included in this Form 10-Q.

Contractual Commitments
Information related to our contractual commitments at December 31, 2012 can be found in a table included within Part II, Item 7 of our 2012 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2013 .

Climate Change
A detailed discussion related to climate change can be found in Part II, Item 7 of our 2012 Form 10-K. There have been no material changes related to climate change from the information reported in our 2012 10-K.

Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Fair-Value Measurements
See Note 17 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.




46
Table of Contents

DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS
Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.
The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.
At September 30, 2013 , our financial instrument position was a net liability of $11.9 million compared to a net liability of $2.2 million at December 31, 2012 . The change in the net financial instrument position was primarily due to larger unrealized gains in our commodity and foreign exchange portfolios.
Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.
Commodity Price Risk
Energy costs are approximately seven percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2013 and December 31, 2012 , with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in an decrease in the net liability position of $3.0 million at September 30, 2013 , compared to a $4.6 million decrease of the net liability position at December 31, 2012 . As a result, at September 30, 2013 the net liability position would have become a net asset. A 10 percent decrease in energy market prices would result in a increase of $2.9 million in the net liability position at September 30, 2013 , compared to an increase of $4.1 million of the net liability position at December 31, 2012 .
Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2013 and December 31, 2012 our net financial instrument position was immaterial.
Foreign Currency Exchange Rate Risk
The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.
To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2013 and December 31, 2012 , with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in an decrease of $16.4 million in the net liability position at September 30, 2013 , compared to a decrease of $5.5 million in the net liability position at December 31, 2012 . As a result, at September 30, 2013 the net liability position would have become a net asset. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in an increase of $24.7 million in the net liability position at September 30, 2013 , compared to a increase of $4.3 million in the net liability position at December 31, 2012 .
Interest Rate Risk
One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2013 and December 31, 2012 , we had no interest rate swap agreements.
Our debt portfolio, at September 30, 2013 , is composed of 45 percent fixed-rate debt and 55 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

47
Table of Contents

Based on the variable-rate debt in our debt portfolio at September 30, 2013 , a one percentage point increase in interest rates then in effect would have increased gross interest expense by $7.1 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $2.6 million for the nine months of September 30, 2013 .

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.
 
ITEM 4.    CONTROLS AND PROCEDURES
(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2013 , the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2013 , that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.


48
Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders
FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2013 , the related condensed consolidated statements of income and comprehensive income for the three-month and nine-month periods ended September 30, 2013 and 2012 , and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2013 and 2012 . These condensed consolidated financial statements are the responsibility of the Company’s management.
We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2012 , and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 19, 2013, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2012 , is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
/s/ KPMG LLP
Philadelphia, Pennsylvania
October 29, 2013


49

PART II - OTHER INFORMATION
 
ITEM 1.    LEGAL PROCEEDINGS

For a discussion of developments in the legal proceedings disclosed in Part I, Item 3 of our 2012 Form 10-K, see Note 18 to the condensed consolidated financial statements included within this Form 10-Q.

ITEM 1A.    RISK FACTORS
In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2012 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
ISSUER PURCHASES OF EQUITY SECURITIES
 
 
 
 
 
 
 
Publicly Announced Program
Period
 
Total Number
of Shares
Purchased
 
Average
Price Paid
Per  Share
 
Total Number of
Shares Purchased
 
Total Dollar
Amount
Purchased
 
Maximum Dollar Value of
Shares that May Yet be
Purchased
Total Q1 2013
 
1,953,737

 
$
59.57

 
1,843,200

 
$
109,872,608

 
$
134,938,705

Total Q2 2013
 
—

 
$
—

 
—

 
—

 
500,000,000

July 1-31, 2013 (1)
 
3,149,828

 
63.58

 
3,145,643

 
200,000,000

 
250,000,000

August 1-31, 2013
 
—

 
—

 
—

 
—

 
250,000,000

September 1-30, 2013
 
—

 
—

 
—

 
—

 
250,000,000

Total Q3 2013
 
3,149,828

 
63.58

 
3,145,643

 
200,000,000

 
250,000,000

Total
 
5,103,565

 
62.05

 
4,988,843

 
309,872,608

 
250,000,000

____________________
(1)
See below discussion on our accelerated share repurchase program, which reduced the remaining authorized amount by $250.0 million.


During the nine months ended September 30, 2013 , we repurchased 4,998,843 shares under the publicly announced repurchase program for $309.9 million . At September 30, 2013 , $250.0 million remained unused under our Board-authorized repurchase program.
On April 23, 2013 our Board-authorized the repurchase of up to $500 million of our common shares. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. The authorization of April 23, 2013 replaced the previous authority under which $134.9 million was unused. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.
In July 2013 we entered into an accelerated share repurchase agreement (ASR) and paid $250 million to a financial institution for an initial delivery of approximately 3.2 million shares, which reduced the our shares outstanding at July 31, 2013. The repurchse is taking place under our previously announced $500 million share repurchase program. The value of the initial shares received on the date of purchase was $200 million, reflecting a $63.58 price per share which was recorded as a treasury share purchase for purposes of calculating earnings per share. We recorded the remaining $50 million as a forward contract indexed to our common stock in additional paid in capital. Final settlement of the ASR, corresponding to the date we will purchase the remaining $50.0 million of common stock under the ASR, is expected to be completed by year end, but may be completed sooner under certain circumstances. The final number of shares that the company is repurchasing under the ASR, the timing of the final settlement, and the aggregate cost will depend upon prevailing market conditions and the final discounted volume-weighted average share price over the term of the ASR.




50
Table of Contents

ITEM 4.    MINE SAFETY DISCLOSURES
Information regarding mine safety and other regulatory actions at our mine in Green River, Wyoming is included in Exhibit 95 to this Form 10-Q.

ITEM 5.    OTHER INFORMATION
None.
ITEM 6.    EXHIBITS
10.1
 
Amendment and Consent No. 1, dated as of August 5, 2013, to the Credit Agreement, dated as of August 5, 2011, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., as Administrative Agent for such lenders.
 
 
 
12
 
Statements of Computation of Ratios of Earnings to Fixed Charges
 
 
 
15
 
Awareness Letter of KPMG LLP
 
 
 
31.1
  
Chief Executive Officer Certification
 
 
 
31.2
  
Chief Financial Officer Certification
 
 
 
32.1
 
CEO Certification of Quarterly Report
 
 
 
32.2
 
CFO Certification of Quarterly Report
 
 
 
95
 
Mine Safety Disclosures
 
 
 
101
 
Interactive Data File



51
Table of Contents


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
FMC CORPORATION
(Registrant)
 
 
 
 
 
 
By:
/ S /   PAUL W. GRAVES        
 
 
Paul W. Graves
Executive Vice President and
Chief Financial Officer
Date: October 29, 2013


52
Table of Contents

INDEX OF EXHIBITS FILED WITH THE
FORM 10-Q OF FMC CORPORATION
FOR THE QUARTER ENDED SEPTEMBER 30, 2013

Exhibit No.
  
Exhibit Description
10.1
  
Amendment and Consent No. 1, dated as of August 5, 2013, to the Credit Agreement, dated as of August 5, 2011, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., as Administrative Agent for such lenders.
 
 
 
12
  
Statements of Computation of Ratios of Earnings to Fixed Charges
 
 
 
15
  
Awareness Letter of KPMG LLP
 
 
 
31.1
  
Chief Executive Officer Certification
 
 
 
31.2
  
Chief Financial Officer Certification
 
 
 
32.1
  
CEO Certification of Quarterly Report
 
 
 
32.2
 
CFO Certification of Quarterly Report
 
 
 
95
 
Mine Safety Disclosures
 
 
 
101
 
Interactive Data File


53

Exhibit 10.1
Execution Version
AMENDMENT AND CONSENT NO. 1
AMENDMENT AND CONSENT NO. 1 , dated as of August 5, 2013 (this “ Amendment and Consent ”), to the Credit Agreement, dated as of August 5, 2011 (as the same may be further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ Credit Agreement ”), among, FMC Corporation, a Delaware corporation (the “ Company ”), certain of the Company’s subsidiaries from time to time party thereto as borrowers (together with the Company, the “ Borrowers ”), Citibank, N.A., as Administrative Agent (as each such term is defined in the Credit Agreement) and each lender and issuing bank from time to time party thereto (collectively, the “ Lenders ” and individually, a “ Lender ”).
WHEREAS, Section 2.15 of the Credit Agreement permits the Company to request an extension of the Termination Date and the Company provided a notice to the Lenders in order to exercise this option on June 24, 2013 (the “ Extension Request ”);
WHEREAS, in addition to the Extension Request, the Company has requested certain other changes to the Credit Agreement as described herein (the “ Proposed Amendments ”);
WHEREAS, Section 9.01 of the Credit Agreement provides that the Company and the Required Lenders may amend the Loan Documents;
WHEREAS, the Lenders party hereto have agreed to grant the Extension Request and approve the Proposed Amendments;
WHEREAS, in order to effect the foregoing, the Company and the other parties hereto desire to amend the Credit Agreement, subject to the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the premises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:
ARTICLE I
Amendment and Consent
SECTION 1.01. Defined Terms. Capitalized terms used herein (including in the recitals hereto) and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement. The rules of construction specified in Section 1.04 of the Credit Agreement also apply to this Amendment and Consent.
SECTION 1.02. Extension Consent. Subject to the terms and conditions set forth herein, on the Amendment and Consent Effective Date each Lender party hereto agrees to extend the Termination Date to August 5, 2017 from August 5, 2016.
SECTION 1.03. Amendment of Credit Agreement. Effective as of the Amendment and Consent Effective Date, the Credit Agreement is hereby amended as follows:
(i)    The following definitions are hereby added in the appropriate
alphabetical order to Section 1.01:


1


“ Amendment and Consent No. 1 ” means that certain Amendment and Consent No. 1 to this Agreement, dated as of August 5, 2013, among the
Company, the Lenders party thereto and the Administrative Agent.
“ Amendment and Consent Effective Date ” has the meaning set forth in the Amendment and Consent No. 1.
(ii) The second whereas clause in the Credit Agreement is hereby amended and restated in its entirety as follows:
WHEREAS, the Borrowers have requested that the Lenders provide a revolving credit facility, the proceeds of which will be used (i) to refinance the existing credit extensions of the Borrowers under the Existing Credit Agreements, (ii) to pay any related transaction costs, fees and expenses and (iii) for general corporate purposes, including issuances of Letters of Credit.
(iii) Section 3.09 of the Credit Agreement is hereby amended and restated in its entirety as follows:
Section 3.09. Use of Proceeds. The Letters of Credit and the proceeds of the Loans shall be available (and each Borrower agrees that it shall use such proceeds) for general corporate purposes of the U.S. Borrower and its Subsidiaries; provided that neither any Lender nor the Administrative Agent shall have any responsibility for the use of any of the Letters of Credit or the proceeds of Loans
(iv) Section 6.03(i) of the Credit Agreement is hereby amended and restated in its entirety as follows:
(i)     Application of Proceeds. The entire amount of the Letters of
Credit or the proceeds of the Loans shall be used by the Borrowers (i) to refinance the existing debt of the Borrowers under the Existing Credit Agreement, (ii) pay any related transaction costs, fees and expenses and (iii) for general corporate purposes.
SECTION 1.04. Effectiveness. Sections 1.02 and 1.03 of this Amendment and Consent shall become effective as of the first date (the “ Amendment and Consent Effective Date ”) on which the following conditions have been satisfied:
(a) The Administrative Agent (or its counsel) shall have received from the Company and the Required Lenders either (x) counterparts of this Amendment and Consent signed on behalf of such parties or (y) written evidence reasonably satisfactory to the Administrative Agent (which may include facsimile or other electronic transmissions of signed signature pages) that such parties have signed counterparts of this Amendment and Consent.
(b) The Administrative Agent shall have received, in immediately available funds, (i) payment or reimbursement of all costs, fees, out-of-pocket expenses, compensation and other amounts then due and payable in connection with this Amendment and Consent, including the reasonable fees, charges and disbursements of


2


counsel for the Administrative Agent and (ii) a nonrefundable amendment fee of 0.05% of the Commitments of each Lender party hereto.
(c) The Administrative Agent shall have received executed legal opinions of: Morgan, Lewis & Bockius LLP, as counsel to the Company substantially in the form of the legal opinion provided on the Effective Date or as otherwise reasonably satisfactory to the Administrative Agent. The Company’s Counsel is expressly instructed to deliver its opinion to the Administrative Agent for the benefit of each of the Administrative Agent and each Lender.
(d) The Administrative Agent shall have received (a) (i) certified copies of the Charter and by-laws (or analogous organizational documents) of the Company and each Borrower or (ii) a certificate of such Borrower dated as of the Amendment and Consent Effective Date confirming that such organizational documents remain in full force and effect as of the date of such certificate, and (b) the resolutions (or analogous authorizations), in form and substance reasonably satisfactory to the Administrative Agent, of the Board of Directors (or analogous governing body) of the Company and each Borrower, authorizing in each case the execution, delivery and performance of this Amendment and Consent, in each case certified by the Secretary or an Assistant Secretary of the Company or such Borrower as of the Amendment and Consent Effective Date and each such certificate shall state that the resolutions thereby certified have not been amended, modified, revoked or rescinded as of the date of such certificate.
(e) The Administrative Agent shall have received a certificate of the Secretary or an Assistant Secretary (or analogous officer) of the Company and each Borrower dated as of the Amendment and Consent Effective Date, as to the incumbency and signature of the officers of the Company and such Loan Party executing each of this Amendment and Consent and each other Loan Document to which the Company and such Borrower is a party, and any certificate or other documents to be delivered by it pursuant thereto, together with evidence of the incumbency of such Secretary or Assistant Secretary as the case may be.
The Administrative Agent shall notify the Company and the Lenders of the Amendment and Consent Effective Date and such notice shall be conclusive and binding.
ARTICLE II
Miscellaneous
SECTION 2.01. Representations and Warranties. (a) To induce the other parties hereto to enter into this Amendment and Consent, the Company represents and warrants to each of the Lenders and the Administrative Agent that, as of the Amendment and Consent Effective Date and after giving effect to the transactions and amendments to occur on the Amendment and Consent Effective Date, this Amendment and Consent has been duly authorized, executed and delivered by the Company and constitutes, and the Credit Agreement, as amended hereby on the Amendment and Consent Effective Date, will constitute, legal, valid and binding obligations of the Borrowers, enforceable against each of the Borrowers in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, moratorium, reorganization or other similar laws affecting creditors’ rights generally and by general principles of equity and the implied covenant of good faith and fair dealing.

3


(b) Each of the representations and warranties made by each party to each Loan Document in or pursuant to this Amendment and Consent or any other Loan Document, or contained in any certificate or financial statement (other than estimates and projections which are (x) identified as such and (y) contained in any financial statement) furnished at any time under or in connection with this Amendment and Consent or any other Loan Document shall be true and correct in all material respects on and as of the Amendment and Consent Effective Date as if made on and as of such date (except to the extent that such representations and warranties relate to a particular date, in which case such representations and warranties shall be true and correct in all material respects on and as of such date), both before and after giving effect to the this Amendment and Consent.
(c) After giving effect to this Amendment and Consent and the transactions contemplated hereby on the relevant date, no Default or Event of Default has occurred and is continuing on the Amendment and Consent Effective Date.
SECTION 2.02. Effect of Amendment and Consent. (a) Except as expressly set forth herein, this Amendment and Consent shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of, the Administrative Agent, the Lenders, any other Agent and any of their respective Affiliates under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. Nothing herein shall be deemed to establish a precedent for purposes of interpreting the provisions of the Credit Agreement or entitle any Borrower to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances. This Amendment and Consent shall apply to and be effective only with respect to the provisions of the Credit Agreement and the other Loan Documents specifically referred to herein.
(b)    On and after the Amendment and Consent Effective Date, each reference
in the Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import, and each reference to the Credit Agreement, “thereunder”, “thereof”, “therein” or words of like import in any other Loan Document, shall be deemed a reference to the Credit Agreement, as amended hereby. This Amendment and Consent shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents.
SECTION 2.03. Governing Law. THIS AMENDMENT AND CONSENT SHALL BE GOVERNED BY, AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK . The other provisions of Article IX of the Credit Agreement shall apply to this Amendment and Consent to the same extent as if fully set forth herein.
SECTION 2.04. Headings. The headings of this Amendment and Consent are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.
[ SIGNATURE PAGES FOLLOW ]


4


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their officers as of the date first above written.

The U.S. Borrower

FMC CORPORATION

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Vice President and Treasurer
 
 
The Euro Borrowers

FMC FINANCE B.V.

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Authorized Signatory, as Attorney-in-Fact
 
FMC CHEMICALS NETHERLANDS B.V.

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Authorized Signatory, as Attorney-in-Fact
 
FMC FORET, S.A.

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Authorized Signatory, as Attorney-in-Fact
 
FMC CHEMICALS GERMANY GMBH

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Authorized Signatory, as Attorney-in-Fact
 

[Amendment and Consent No. 1]

SURETY INTERNATIONAL LTD.

By:     /s/ Thomas C. Deas, Jr.          
   Name: Thomas C. Deas, Jr.
   Title: Authorized Signatory, as Attorney-in-Fact
 


[Amendment and Consent No. 1]

CITIBANK, N.A.
as Administrative Agent

By:     /s/ Shannon Sweeney        
Name:    Shannon Sweeney
Title:    Vice President

[Amendment and Consent No. 1]


CITIBANK, N.A., as a Lender and an Issuing Bank

By:     /s/ Shannon Sweeney          
   Name: Shannon Sweeney
   Title: Vice President


[Amendment and Consent No. 1]


BANK OF AMERICA, N.A., as a Lender and an Issuing Bank

By:     /s/ Darren Bielawski          
   Name: Darren Bielawski
   Title: Assistant Vice President


[Amendment and Consent No. 1]


THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., as Lender

By:     /s/ George Stoecklein          
   Name: George Stoecklein
   Title: Director


[Amendment and Consent No. 1]


DNB Bank ASA, Grand Cayman Branch, as Lender

By:     /s/ Philip F. Kurpiewski          
   Name: Philip F. Kurpiewski
   Title: Senior Vice President
 
 
By:     /s/ Bjorn Erik Hammerstad       
   Name: Bjorn Erik Hammerstad
   Title: Senior Vice President


[Amendment and Consent No. 1]


Sumitomo Mitsui Banking Corporation, as Lender

By:     /s/ James D. Weinstein          
   Name: James D. Weinstein
   Title: Managing Director


[Amendment and Consent No. 1]


BNP Paribas, as Lender

By:     /s/ Michael Hoffman          
   Name: Michael Hoffman
   Title: Vice President
 
 
By:     /s/ Todd Grossnickle          
   Name: Todd Grossnickle
   Title: Vice President


[Amendment and Consent No. 1]


HSBC Bank USA, National Association, as Lender

By:     /s/ David A. Mandell          
   Name: David A. Mandell
   Title: Managing Director


[Amendment and Consent No. 1]


U.S. Bank, National Association, as Lender

By:     /s/ Robert C. Mayer, Jr.          
   Name: Robert C. Mayer, Jr.
   Title: Vice President


[Amendment and Consent No. 1]


TD Bank, N.A., as Lender

By:     /s/ Bernadette Collins          
   Name: Bernadette Collins
   Title: Senior Vice President


[Amendment and Consent No. 1]


CoBank, ACB, as Lender

By:     /s/ Alan Schuler          
   Name: Alan Schuler
   Title: Vice President


[Amendment and Consent No. 1]


Citizens Bank of Pennsylvania, as Lender

By:     /s/ Leslie D. Broderick          
   Name: Leslie D. Broderick
   Title: Senior Vice President


[Amendment and Consent No. 1]


LLOYDS TSB BANK PLC, as Lender

By:     /s/ Karen Weich             
   Name: Karen Weich
   Title: Vice President - W011
 
 
By:     /s/ Dennis McClellan          
   Name: Dennis McClellan
   Title: Vice President - M040
 


[Amendment and Consent No. 1]


Wells Fargo Bank, N.A., as Lender

By:     /s/ James Travagline          
   Name: James Travagline
   Title: Director


[Amendment and Consent No. 1]


JPMORGAN CHASE BANK, N.A., as Lender

By:     /s/ James A. Knight             
   Name: James A. Knight
   Title: Vice President


[Amendment and Consent No. 1]


Branch Banking and Trust Company, as Lender

By:     /s/ Glenn A. Page             
   Name: Glenn A. Page
   Title: Senior Vice President


[Amendment and Consent No. 1]


KBC Bank, N.V. – New York Branch as Lender

By:     /s/ Sheila Bermejo             
   Name: Sheila Bermejo
   Title: Vice President
 
 
By:     /s/ Thomas R. Lalli          
   Name: Thomas R. Lalli
   Title: Managing Director
 


[Amendment and Consent No. 1]


THE BANK OF NEW YORK MELLON, as Lender

By:     /s/ William M. Feathers             
   Name: William M. Feathers
   Title: Vice President


[Amendment and Consent No. 1]


Australia and New Zealand Banking Group Limited, as Lender

By:     /s/ Robert Grillo             
   Name: Robert Grillo
   Title: Director


[Amendment and Consent No. 1]


Bank of China, New York Branch, as Lender

By:     /s/ Haifeng Xu             
   Name: Haifeng Xu
   Title: Executive Vice President


[Amendment and Consent No. 1]


 
Exhibit 12
FMC CORPORATION
STATEMENTS OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
 
(in Millions, Except Ratios)
Nine Months Ended September 30
2013
 
2012
Earnings:
 
 
 
Income from continuing operations before income taxes
$
447.5

 
$
467.4

Equity in (earnings) loss of affiliates
0.5

 
0.3

Interest expense and amortization of debt discount, fees and expenses
31.4

 
30.3

Amortization of capitalized interest
3.3

 
3.1

Interest included in rental expense
1.8

 
3.7

Total earnings
$
484.5

 
$
504.8

Fixed charges:
 
 
 
Interest expense and amortization of debt discount, fees and expenses
$
31.4

 
$
30.3

Interest capitalized as part of fixed assets
4.4

 
5.6

Interest included in rental expense
1.8

 
3.7

Total fixed charges
$
37.6

 
$
39.6

Ratio of earnings to fixed charges (1)
12.9

  
12.7


(1)
In calculating this ratio, earnings consist of income (loss) from continuing operations before income taxes plus interest expense, net, amortization expense related to debt discounts, fees and expenses, amortization of capitalized interest, interest included in rental expenses (assumed to be one-third of rent) and Equity in (earnings) loss of affiliates. Fixed charges consist of interest expense, amortization of debt discounts, fees and expenses, interest capitalized as part of fixed assets and interest included in rental expenses.
 

 





Exhibit 15

Letter re: Unaudited Interim Financial Information
October 29, 2013

FMC Corporation
Philadelphia, Pennsylvania
Re: Registration Statements on Form S-3 (No. 333-184736) and Form S-8 (Nos. 333-64702, 333-62683, 333-36973, 333-24039, 333-18383, 333-69805, 333-69714, 333-111456, 333-172387 and 333-172388).
With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated October 29, 2013 related to our review of interim financial information.
Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP
Philadelphia, Pennsylvania







Exhibit 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Pierre R. Brondeau, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of FMC Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 

Date: October 29, 2013
 
/s/ Pierre R. Brondeau
 
Pierre R. Brondeau
President and Chief Executive Officer
 




Exhibit 31.2
CHIEF FINANCIAL OFFICER CERTIFICATION
I, Paul W. Graves, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of FMC Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 

Date: October 29, 2013
 
/s/ Paul W. Graves
 
Paul W. Graves
Executive Vice President and
Chief Financial Officer
 





  Exhibit 32.1
CEO CERTIFICATION OF QUARTERLY REPORT
I, Pierre R. Brondeau, President and Chief Executive Officer of FMC Corporation (“the Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, based on my knowledge that:
(1)
the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 29, 2013
 
/s/ Pierre R. Brondeau
Pierre R. Brondeau
President and Chief Executive Officer
 




  Exhibit 32.2
CFO CERTIFICATION OF QUARTERLY REPORT
I, Paul W. Graves, Executive Vice President and Chief Financial Officer of FMC Corporation (“the Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, based on my knowledge that:
(1)
the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 29, 2013
 
/s/ Paul W. Graves
Paul W. Graves
Executive Vice President and
Chief Financial Officer
 





Exhibit 95
MINE SAFETY DISCLOSURES

Section 1503 of the Dodd-Frank Act contains new reporting requirements regarding coal or other mine safety. We operate a mine in conjunction with our Green River, Wyoming facility, which is subject to regulation by the Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977 (the “Mine Act”), and is therefore subject to these reporting requirements. Presented in the table below is information regarding certain mining safety and health citations which MSHA has issued with respect to our operation as required by the Dodd-Frank Act. In evaluating this information, consideration should be given to the fact that citations and orders can be contested and appealed, and in that process, may be reduced in severity, penalty amount or sometimes dismissed (vacated) altogether.

The letters used as column headings in the table below correspond to the explanations provided underneath the table as to the information set forth in each column with respect to the numbers of violations, orders, citations or dollar amounts, as the case may be, during the third quarter 2013 unless otherwise indicated.
(1)
For each coal or other mine, of which the issuer or a subsidiary of the issuer is an operator:
 
 
(A)
 
(B)
 
(C)
 
(D)
 
(E)
 
(F)
 
(G)
 
(H)
Operation
Name
 
Section
104
 
Section
104(b)
 
Section
104(d)
 
Section
110(b)(2)
 
Section
107(a)
 
Proposed
Assessments*
 
Fatalities
 
Pending
Legal
Action
Westvaco
 
27

 
—

 
—

 
—

 
—

 
Not Assessed
 
—

 
2

____________________
*
Assessments are generally delayed up to 60 days after the close of the inspection.     
(A)
The total number of violations of mandatory health or safety standards that could significantly and substantially contribute to the cause and effect of a coal or other mine safety and health hazard under section 104 of the Mine Act for which the operator received a citation from MSHA.
(B)
The total number of orders issued under section 104(b) of the Mine Act.
(C)
The total number of citations and orders for unwarrantable failure of the operator to comply with mandatory health or safety standards under section 104(d) of the Mine Act.
(D)
The total number of flagrant violations under section 110(b)(2) of the Mine Act.
(E)
The total number of imminent danger orders issued under section 107(a) of the Mine Act.
(F)
The total dollar value of proposed assessments from the MSHA under the Mine Act.
(G)
The total number of mining related fatalities.
(H)
Any pending legal action before the Federal Mine Safety and Health Review Commission involving such coal or other mines.
a.
All cases included in the number listed were pending before the Office of Administrative Law Judges of the Federal Mine Safety and Health Review Commission on September 30, 2013.
(2)
A list of such coal or other mines, of which the issuer or a subsidiary of the issuer is an operator, that received written notice from MSHA of (A) a pattern of violations of mandatory health or safety standards that are of such nature as could have significantly and substantially contributed to the cause and effect of coal or other mine health and safety hazards under section 104(e) of the Mine Act, or (B) the potential to have such a pattern.
      NONE
(3)
Any pending legal action before the Federal Mine Safety and Health Review Commission involving such coal or other mine.
      SEE COLUMN (H) OF SECTION (1) ABOVE